<article itemscope="" itemtype="http://schema.org/Article" data-itemscope="root">
  <h1 itemprop="headline"
    content="Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfac…">
    Optimizing antibody affinity and stability by the automated design of the variable light-heavy
    chain interfaces</h1>
  <meta itemprop="image"
    content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Optimizing%20antibody%20affinity%20and%20stability%20by%20the%20automated%20design%20of%20the%20variable%20light-heavy%20chain%20interfac%E2%80%A6">
  <ol data-itemprop="authors">
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Shira Warszawski"><span data-itemprop="givenNames"><span
          itemprop="givenName">Shira</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Warszawski</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-1">1</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Aliza Borenstein Katz"><span data-itemprop="givenNames"><span
          itemprop="givenName">Aliza</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Borenstein</span><span itemprop="familyName">Katz</span></span><span
        data-itemprop="affiliations"><a itemprop="affiliation"
          href="#author-organization-2">2</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Rosalie Lipsh"><span data-itemprop="givenNames"><span
          itemprop="givenName">Rosalie</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Lipsh</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-1">1</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Lev Khmelnitsky"><span data-itemprop="givenNames"><span
          itemprop="givenName">Lev</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Khmelnitsky</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-2">2</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Gili Ben Nissan"><span data-itemprop="givenNames"><span
          itemprop="givenName">Gili</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Ben</span><span itemprop="familyName">Nissan</span></span><span
        data-itemprop="affiliations"><a itemprop="affiliation"
          href="#author-organization-1">1</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Gabriel Javitt"><span data-itemprop="givenNames"><span
          itemprop="givenName">Gabriel</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Javitt</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-2">2</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Orly Dym"><span data-itemprop="givenNames"><span
          itemprop="givenName">Orly</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Dym</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-3">3</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Tamar Unger"><span data-itemprop="givenNames"><span
          itemprop="givenName">Tamar</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Unger</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-3">3</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Orli Knop"><span data-itemprop="givenNames"><span
          itemprop="givenName">Orli</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Knop</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-1">1</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Shira Albeck"><span data-itemprop="givenNames"><span
          itemprop="givenName">Shira</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Albeck</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-3">3</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Ron Diskin"><span data-itemprop="givenNames"><span
          itemprop="givenName">Ron</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Diskin</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-2">2</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Deborah Fass"><span data-itemprop="givenNames"><span
          itemprop="givenName">Deborah</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Fass</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-2">2</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Michal Sharon"><span data-itemprop="givenNames"><span
          itemprop="givenName">Michal</span></span><span data-itemprop="familyNames"><span
          itemprop="familyName">Sharon</span></span><span data-itemprop="affiliations"><a
          itemprop="affiliation" href="#author-organization-1">1</a></span></li>
    <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
      <meta itemprop="name" content="Sarel J. Fleishman"><span data-itemprop="givenNames"><span
          itemprop="givenName">Sarel</span><span itemprop="givenName">J.</span></span><span
        data-itemprop="familyNames"><span itemprop="familyName">Fleishman</span></span><span
        data-itemprop="affiliations"><a itemprop="affiliation"
          href="#author-organization-1">1</a></span></li>
  </ol>
  <ol data-itemprop="affiliations">
    <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-1"
      id="author-organization-1"><span itemprop="name">Department of Biomolecular Sciences, Weizmann
        Institute of Science, Rehovot, Israel</span></li>
    <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-2"
      id="author-organization-2"><span itemprop="name">Department of Structural Biology, Weizmann
        Institute of Science, Rehovot, Israel</span></li>
    <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-3"
      id="author-organization-3"><span itemprop="name">Israel Structural Proteomics Center, Weizmann
        Institute of Science, Rehovot, Israel</span></li>
  </ol><span itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
    <meta itemprop="name" content="Unknown"><span itemscope=""
      itemtype="http://schema.org/ImageObject" itemprop="logo">
      <meta itemprop="url"
        content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
      </span></span><time itemprop="datePublished" datetime="2019-08-23">2019-08-23</time>
  <ul data-itemprop="identifiers">
    <li itemscope="" itemtype="http://schema.org/PropertyValue" itemprop="identifier">
      <meta itemprop="propertyID" content="https://registry.identifiers.org/registry/doi"><span
        itemprop="name">doi</span><span itemprop="value">10.1371/journal.pcbi.1007207</span></li>
    <li itemscope="" itemtype="http://schema.org/PropertyValue" itemprop="identifier">
      <meta itemprop="propertyID" content="https://registry.identifiers.org/registry/publisher-id">
      <span itemprop="name">publisher-id</span><span itemprop="value">PCOMPBIOL-D-19-00192</span>
    </li>
    <li itemscope="" itemtype="http://schema.org/PropertyValue" itemprop="identifier">
      <meta itemprop="propertyID" content="https://registry.identifiers.org/registry/elocation-id">
      <span itemprop="name">elocation-id</span><span itemprop="value">e1007207</span></li>
  </ul>
  <section data-itemprop="description">
    <h2 data-itemtype="http://schema.stenci.la/Heading">Abstract</h2>
    <meta itemprop="description"
      content="Antibodies developed for research and clinical applications may exhibit suboptimal stability, expressibility, or affinity. Existing optimization strategies focus on surface mutations, whereas natural affinity maturation also introduces mutations in the antibody core, simultaneously improving stability and affinity. To systematically map the mutational tolerance of an antibody variable fragment (Fv), we performed yeast display and applied deep mutational scanning to an anti-lysozyme antibody and found that many of the affinity-enhancing mutations clustered at the variable light-heavy chain interface, within the antibody core. Rosetta design combined enhancing mutations, yielding a variant with tenfold higher affinity and substantially improved stability. To make this approach broadly accessible, we developed AbLIFT, an automated web server that designs multipoint core mutations to improve contacts between specific Fv light and heavy chains (http://AbLIFT.weizmann.ac.il). We applied AbLIFT to two unrelated antibodies targeting the human antigens VEGF and QSOX1. Strikingly, the designs improved stability, affinity, and expression yields. The results provide proof-of-principle for bypassing laborious cycles of antibody engineering through automated computational affinity and stability design.">
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Antibodies developed for research
      and clinical applications may exhibit suboptimal stability, expressibility, or affinity.
      Existing optimization strategies focus on surface mutations, whereas natural affinity
      maturation also introduces mutations in the antibody core, simultaneously improving stability
      and affinity. To systematically map the mutational tolerance of an antibody variable fragment
      (Fv), we performed yeast display and applied deep mutational scanning to an anti-lysozyme
      antibody and found that many of the affinity-enhancing mutations clustered at the variable
      light-heavy chain interface, within the antibody core. Rosetta design combined enhancing
      mutations, yielding a variant with tenfold higher affinity and substantially improved
      stability. To make this approach broadly accessible, we developed AbLIFT, an automated web
      server that designs multipoint core mutations to improve contacts between specific Fv light
      and heavy chains (<a href="http://ablift.weizmann.ac.il/" itemscope=""
        itemtype="http://schema.stenci.la/Link">http://AbLIFT.weizmann.ac.il</a>). We applied AbLIFT
      to two unrelated antibodies targeting the human antigens VEGF and QSOX1. Strikingly, the
      designs improved stability, affinity, and expression yields. The results provide
      proof-of-principle for bypassing laborious cycles of antibody engineering through automated
      computational affinity and stability design.</p>
  </section>
  <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec001">Introduction</h2>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">High-affinity natural antibodies are
    generated through an iterative process of mutation and selection for antigen binding known as
    affinity maturation. Affinity maturation also selects antibodies that exhibit higher stability
    and expressibility [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref001">1</a></cite>], both of which are essential parameters in the
    development of antibodies into research or medical tools [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref002">2</a></cite>]. In
    recent decades, synthetic antibody repertoires have been widely adopted in antibody discovery
    and optimization, providing greater control over the selection process than animal immunization.
    In this approach, a library of antibody variable fragments (Fv) is displayed, for instance on
    yeast cells, and screened to select high-affinity binders or to improve the affinity of existing
    antibodies [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref003">3</a></cite>]. These methods are powerful [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref004">4</a></cite>,<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref005">5</a></cite>], but a large fraction of high-affinity antibodies
    isolated from synthetic repertoires exhibits impaired stability [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref006">6</a></cite>]. Impaired
    stability can limit expression yields and increase aggregation propensity [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref007">7</a></cite>],
    resulting in high production costs [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref008">8</a></cite>], fast
    antibody clearance from circulation and adverse immune responses in patients [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref009">9</a></cite>]. Thus,
    the tradeoff between antibody stability (including solubility and expressibility) and affinity
    can delay and even block the development of antibodies in research and medicine [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref010">10</a></cite>]. General methods to improve antibody stability
    while maintaining or even increasing affinity are therefore urgently needed to reduce the
    attrition rate in antibody development pipelines [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref011">11</a></cite>].</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">To boost antibody stability and
    affinity, computational design methods have been developed. These have focused on the Fv
    complementarity-determining regions (CDRs), which are typically in direct contact with the
    antigen. Some methods, for instance, improved electrostatic complementarity with the antigen
    [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref012">12</a></cite>] or eliminated hydrophobic surface patches [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref013">13</a></cite>–<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref018">18</a></cite>]. Natural
    and laboratory affinity maturation, by contrast, introduce mutations in both the CDRs and the
    antibody core [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref001">1</a></cite>,<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref005">5</a></cite>]. Core
    mutations may improve antibody stability by eliminating packing defects, and they may enhance
    affinity by preorganizing the antigen-binding site [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref001">1</a></cite>]. Although
    mutations in the core may contribute less to affinity than ones in the CDRs, they are more
    likely to retain the intricate structure of the antigen-binding site and are therefore likely to
    be compatible with affinity-enhancing mutations in the CDRs that were obtained through other
    optimization strategies. The antibody core, however, is a large and densely packed region,
    complicating the design of improved variants [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref005">5</a></cite>,<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref019">19</a></cite>]. For instance, we recently presented and
    validated an automated computational strategy, called PROSS [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref020">20</a></cite>], for
    protein-stability design. Similar to other stability design algorithms [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref021">21</a></cite>],
    however, PROSS only rarely introduces core mutations and does not improve binding affinity
    [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref022">22</a></cite>]. Reliable prediction of mutational effects in the
    antibody core and especially successful design of networks of interacting multipoint core
    mutations has, therefore, remained a challenge [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref021">21</a></cite>,<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref023">23</a></cite>].</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Recently, deep mutational scanning
    has been successfully applied to study the mutational tolerance of antibodies and other binders
    [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref024">24</a></cite>–<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref030">30</a></cite>]. In this
    approach, amino acid positions in the binder are systematically mutated to all of the natural
    amino acid identities; the mutants are pooled into one library containing all single-point
    mutations; populations of binders are selected from this library using <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">in vitro</em> display and high-throughput
    screening; and the selected and unselected populations are subjected to deep-sequencing analysis
    to infer which mutations are enriched relative to the starting binder, thus systematically
    identifying affinity-enhancing mutations. Deep mutational scanning has been very successfully
    used to guide protein design and engineering of improved binders [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref024">24</a></cite>,<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref026">26</a></cite>,<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref031">31</a></cite>,<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref032">32</a></cite>] but has not yet been exploited to improve
    protein-design methodology itself. The large improvements in the reliability and breadth of
    detection of affinity-enhancing mutations through deep mutational scanning inspired us to
    revisit the challenge of accurately predicting the effects of core mutations on antibody
    affinity and stability. Deep mutational scanning guided us in uncovering a cluster of core
    positions at the light-heavy chain (vL-vH) interface where many affinity-enhancing mutations
    occurred. We then used these systematic data to establish general rules for computational design
    of antibody Fvs with improved vL-vH interactions; we implemented these rules as an automated
    method, called AbLIFT and made it available through a web server (<a
      href="http://ablift.weizmann.ac.il/" itemscope=""
      itemtype="http://schema.stenci.la/Link">http://AbLIFT.weizmann.ac.il</a>). AbLIFT designs
    exhibited striking gains in affinity, stability, and expressibility in two unrelated antibodies
    that target the human disease markers Vascular-Epidermal Growth Factor (VEGF) and the enzyme
    Quiescin Sulfhydryl Oxidase 1 (QSOX1).</p>
  <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec002">Results</h2>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec003">A cluster of
    affinity-enhancing mutations at the vL-vH interface</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">To study the mutational tolerance of
    an antibody Fv, we selected 135 positions in the anti-lysozyme antibody D44.1 [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref033">33</a></cite>] for deep mutational scanning (<strong
      itemscope="" itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s001"
        itemscope="" itemtype="http://schema.stenci.la/Link">S1A Fig</a></strong>). The positions
    encompassed most of the CDRs, the vL-vH interface and additional peripheral positions (<strong
      itemscope="" itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g001"
        itemscope="" itemtype="http://schema.stenci.la/Link">Fig 1A</a></strong>). D44.1 and each
    point mutant were genetically encoded as single-chain variable fragments (scFv) in which the
    heavy chain was fused to the light chain via a flexible linker, and the genes were transformed
    into yeast cells for binding and expression screens by yeast display [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref003">3</a></cite>].
    Following incubation with hen egg-white lysozyme, the top 15% binders were selected from this
    library, and the same library was also subjected to low-stringency selection for expression
    levels to provide a baseline. The plasmids containing scFv-encoding genes from both selections
    were purified, amplified by PCR, and subjected to deep sequencing, resulting in 8 million
    high-quality reads [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref032">32</a></cite>]. We then determined the enrichment of each mutant
    relative to D44.1 as the ratio between populations selected for binding and expression (<strong
      itemscope="" itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g001"
        itemscope="" itemtype="http://schema.stenci.la/Link">Fig 1B</a></strong>).</p>
  <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pcbi-1007207-g001"
    title="Fig 1"><img src="/thema/examples/articleAntibodies.html.media/g001.png" alt="" itemscope=""
      itemtype="http://schema.org/ImageObject">
    <figcaption>
      <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
        id="deep-mutational-scanning-of-an-antibody-variable-fragment-fv">Deep mutational scanning
        of an antibody variable fragment (Fv).</h4>
      <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">a</strong>) 135 positions across the Fv of the
        anti-lysozyme antibody D44.1 (encompassing the vL-vH interface and all positions from the
        antigen-binding surface to the level of the disulfide-linked cysteines) were individually
        diversified using degenerate codons (NNS) to encode all point mutations. The variants were
        transformed into yeast cells, subjected to low-stringency selection for binding (green
        spots) and for expression (purple + green spots), and then to deep-sequencing analysis.
        (<strong itemscope="" itemtype="http://schema.stenci.la/Strong">b</strong>) 34 Fv positions
        exhibited enhanced binding upon mutation (blue). Amino acids (x-axis) are numbered according
        to ref. [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
            href="#pcbi-1007207-ref033">33</a></cite>]. Blue, red and gray encode mutations that are
        enriched, depleted, or ones with insufficient data, respectively. Amino acid identities in
        the parental antibody are indicated in one-letter code for each position. (<strong
          itemscope="" itemtype="http://schema.stenci.la/Strong">c</strong>) At several positions,
        more than five alternative identities enhanced affinity, indicating that the combinatorial
        sequence space of affinity-enhancing multipoint mutants is large. Positions at the vL-vH
        interface are colored purple. (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">d</strong>) Mutations were ranked according to
        their enrichment ratios, revealing that many (30%) of the top affinity-enhancing mutations
        occurred at the vL-vH interface (30 identities at the eight positions with enrichment over
        the parental identity above threefold are marked in blue triangles). (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">e</strong>) Spheres indicate positions on the
        molecular structure of the bound HEL-D44.1 complex (PDB entry 1MLC) in which mutations
        exhibited at least threefold enrichment relative to D44.1. A cluster of enriched positions
        at the vL-vH interface, mostly belonging to the antibody framework, is highlighted in
        purple. HEL—hen egg-white lysozyme.</p>
    </figcaption>
  </figure>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">We found affinity-enhancing mutations
    at 34 positions, mostly within the CDRs, as expected (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g001" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 1C</a></strong>). We also noticed a surprisingly
    large cluster of eight positions at the vL-vH interface where affinity-enhancing mutations
    occurred, although they were not in direct contact with the antigen (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g001" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 1D and 1E</a></strong>). This cluster of
    affinity-enhancing mutations in the vL-vH interface is intriguing for four reasons: (1) the
    vL-vH interface mediates the assembly of the Fv from the two antibody chains, and mutations in
    this region have the potential to also enhance stability through improved Fv assembly [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref001">1</a></cite>]; (2) the genetic pairing of light and heavy chains
    during germline antibody generation is a random process which may result in suboptimal vL-vH
    interfaces, flexibility in the antigen-binding site [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref034">34</a></cite>], and
    therefore in lower antigen affinity [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref035">35</a></cite>]; (3)
    this region is distant from the mutational hotspots in the CDRs and may not be fully optimized
    in the course of natural affinity maturation [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref036">36</a></cite>]; and (4)
    antibody-engineering procedures, such as humanization or CDR grafting may inadvertently
    compromise the structural integrity of this region by mispairing CDRs and frameworks [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref037">37</a></cite>]. Based on these considerations, we hypothesized
    that the vL-vH interface may be especially amenable to the design of multipoint mutants that
    simultaneously improve stability and affinity in both natural and engineered antibodies.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Combining mutations in densely packed
    protein cores, such as the vL-vH interface, is challenging, however, because inadvertently
    introduced voids, steric overlaps, or mispaired polar amino acid side-chains can lead to protein
    instability, misfolding, and aggregation [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref021">21</a></cite>,<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref023">23</a></cite>]. We, therefore, asked whether the
    mutational-tolerance map could guide Rosetta design in finding improved multipoint mutants at
    the vL-vH interface. In preliminary calculations starting from the lysozyme-bound D44.1
    structure (PDB entry: 1MLC), we restricted Rosetta combinatorial design to the eight positions
    and 38 identities (including the wild type identities) at these positions that showed at least
    threefold enrichment relative to D44.1 according to the mutational-tolerance map (<strong
      itemscope="" itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g001"
        itemscope="" itemtype="http://schema.stenci.la/Link">Fig 1B and 1E</a></strong>). The
    resulting design, however, comprised only three conservative mutations, suggesting that the
    dense packing and backbone rigidity at the vL-vH interface restricted sequence optimization. We,
    therefore, repeated design calculations but this time excluded the wild type identities at the
    eight positions, forcing the design of an optimal combination of mutations only from those that
    were substantially enriched in deep mutational scanning. We iterated sequence design and
    backbone and sidechain minimization to promote the acceptance of even radical mutations yielding
    design D44.1<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup> with
    eight mutations. As a preliminary qualitative test, we analyzed D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> binding to lysozyme and to seven of
    the eight single-point mutations formatted as scFvs using yeast display [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref003">3</a></cite>]. As
    expected, each of the point mutations improved the apparent binding affinity relative to D44.1;
    and yet, the multipoint D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> exhibited a substantial improvement
    in apparent affinity compared to the single-point mutations (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s001" itemscope=""
        itemtype="http://schema.stenci.la/Link">S1B Fig</a></strong>).</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">To determine what molecular factors
    might underlie higher affinity in D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup>, we expressed the design as an
    antigen-binding fragment (Fab) and determined its structure by X-ray crystallography in the
    absence of lysozyme (<strong itemscope="" itemtype="http://schema.stenci.la/Strong"><a
        href="#pcbi-1007207-s007" itemscope="" itemtype="http://schema.stenci.la/Link">S1
        Table</a></strong>). Despite eight core mutations, the overall agreement between D44.1<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup> and the bound structure
    of D44.1, which served as the starting point for designing D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup>, was excellent (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s002" itemscope=""
        itemtype="http://schema.stenci.la/Link">S2 Fig</a></strong>): The two structures deviated by
    &lt;1 Å backbone root-mean-square deviation (rmsd) and in side-chain residues comprising the
    lysozyme-binding site. The mutations apparently improved various molecular aspects of the vL-vH
    interface including interface packing, solvation, and backbone rigidity (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g002" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 2A</a></strong>). Next, we tested lysozyme
    binding by D44.1 and D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> (both expressed and purified as Fab)
    using surface-plasmon resonance (SPR). D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> exhibited nearly tenfold improvement
    in affinity (<em itemscope="" itemtype="http://schema.stenci.la/Emphasis">K</em><sub
      itemscope="" itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
        itemtype="http://schema.stenci.la/Emphasis">D</em></sub> of 15 versus 135 nM for D44.1<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup> and D44.1,
    respectively), with a 25-fold slower off-rate (8 * 10<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">−4</sup> s<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">-1</sup>) (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g002" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 2B</a></strong>). D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> also exhibited improved thermal
    denaturation and aggregation resistance (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g002" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 2C and 2D</a></strong>).</p>
  <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pcbi-1007207-g002"
    title="Fig 2"><img src="/thema/examples/articleAntibodies.html.media/g002.png" alt="" itemscope=""
      itemtype="http://schema.org/ImageObject">
    <figcaption>
      <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
        id="gains-in-affinity-stability-and-aggregation-resistance-through-vl-vh-interface-design-guided-by-deep-mutational-scanning">
        Gains in affinity, stability, and aggregation resistance through vL-vH interface design
        guided by deep mutational scanning.</h4>
      <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">a</strong>) Comparison of the starting
        anti-lysozyme antibody D44.1 and the crystal structure of design D44.1<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des</sup> (PDB entries: 1MLC and 6GC2,
        respectively) showed improved interactions across the interface and likely increased
        backbone rigidity. (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">b</strong>) SPR kinetic analysis of hen
        egg-white lysozyme (HEL) binding with threefold dilutions of HEL from a maximal
        concentration of 333 nM for D44.1 and 111 nM for D44.1<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des</sup> (kinetic fits shown in gray).
        D44.1 exhibited <em itemscope="" itemtype="http://schema.stenci.la/Emphasis">k</em><sub
          itemscope="" itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">a</em></sub> = 1.5 * 10<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">5</sup> M<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>, <em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">k</em><sub itemscope=""
          itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">d</em></sub> = 0.021 s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>, and <em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">K</em><sub itemscope=""
          itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">D</em></sub> = 137 nM. D44.1<sup
          itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup> exhibited <em
          itemscope="" itemtype="http://schema.stenci.la/Emphasis">k</em><sub itemscope=""
          itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">a</em></sub> = 5.3 * 10<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">4</sup> M<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>, <em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">k</em><sub itemscope=""
          itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">d</em></sub> = 7.9 * 10<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">−4</sup> s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>, and <em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">K</em><sub itemscope=""
          itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">D</em></sub> = 15 nM (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">c &amp; d</strong>) Thermal denaturation and
        temperature of aggregation onset, respectively, of D44.1 and D44.1<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des</sup> formatted as Fabs using
        microscale thermophoresis. (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">e</strong>) A potential molecular explanation
        for improved affinity. The unbound (cyan) and bound (gray) structures of D44.1 (PDB entries:
        1MLB and 1MLC, respectively) exhibit a different H2 backbone conformation; the former
        sterically hinders lysozyme binding. The high-affinity anti-lysozyme antibody F10.6.6 in its
        unbound form (PDB entry: 2Q76; orange) and D44.1<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des</sup> (pink) are similar to one another
        and to the bound conformation of D44.1 and are compatible with binding HEL. (inset) a
        closeup of the H2 backbone conformation revealing that the D44.1 H2 backbone (cyan)
        sterically overlaps with lysozyme, whereas all the other backbone conformations are
        compatible with lysozyme binding. The Trp47<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">H</sup>Tyr mutation in D44.1<sup
          itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup> alters packing at
        the base of CDR H2 and may induce the observed conformational change in the design.</p>
    </figcaption>
  </figure>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">We also compared the molecular
    structure of D44.1<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup> to
    the unbound structure of D44.1 (PDB entry: 1MLB). The main difference between the two structures
    was localized to the backbone conformation of CDR H2: Whereas H2 in the unbound structure of
    D44.1 adopts a conformation that would sterically overlap with lysozyme in the bound structure,
    the H2 backbone of D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> moves away from this position such
    that, even in the unbound state, the design is sterically compatible with lysozyme binding. The
    H2 backbone conformation of D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> is not identical but is similar to
    the H2 conformation in the bound D44.1 structure and also to the conformation observed in the
    unbound structure of the high-affinity anti-lysozyme antibody F10.6.6 (PDB entry: 1P2C) (<strong
      itemscope="" itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g002"
        itemscope="" itemtype="http://schema.stenci.la/Link">Fig 2E</a></strong>). Although it is
    possible that the observed conformational differences among the structures are due to
    differences in crystallographic conditions, we note that the mutation Trp47<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">H</sup>Tyr in D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> is incompatible with the observed H2
    conformation in the unbound state of D44.1 and may induce the observed change in the design’s
    backbone conformation. Hence, the structure-based analysis suggested that the design of the
    vL-vH interface based on the bound antibody structure might increase the compatibility of the
    CDR backbones for the ligand while simultaneously improving stability.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec004">Computational
    mutation-tolerance mapping</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The successful optimization of
    antibody affinity and stability encouraged us to fully automate the design procedure,
    eliminating the requirement for experimental deep mutational scanning. We, therefore, sought a
    general computational strategy that would predict which mutations in the vL-vH interface were
    likely to enhance affinity and stability, with the goal of developing a general computational
    procedure for mutational-tolerance mapping. To achieve this goal, we exploited the large
    experimental dataset of the D44.1 mutational tolerance map, comprising 2,294 point mutations,
    for training. At each of the mutated D44.1 Fv positions, we used Rosetta to compute the changes
    to native-state energy due to each of the 19 amino acid mutations (ΔΔ<em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">G</em>). Using a multiple-sequence alignment of
    homologous Fvs, we additionally computed each point mutation’s evolutionary-conservation score,
    as represented in a Position-Specific Scoring Matrix (PSSM) [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref038">38</a></cite>]. These
    two computed parameters provide complementary predictions of mutational tolerance: the former
    predicts the impact of a mutation on native-state stability and the latter discriminates between
    evolutionarily tolerated mutations and those that have been purged by evolution. The use of
    these two parameters has recently led to substantial improvement in design accuracy in binder
    and enzyme design challenges in our laboratory [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref020">20</a></cite>–<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref022">22</a></cite>,<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref038">38</a></cite>–<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref043">43</a></cite>]. We specifically used these two parameters
    because they can be computed for any antibody given an accurate experimental or model structure,
    allowing us, in principle, to compute mutational tolerance maps for any antibody Fv.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">We systematically screened different
    combinations of ΔΔ<em itemscope="" itemtype="http://schema.stenci.la/Emphasis">G</em> and PSSM
    thresholds to determine which combination optimally discriminates enhancing from deleterious
    mutations as observed in the experimental mutational-tolerance map of D44.1. We defined the
    prediction true-positive rate (TPR) as the proportion of correctly predicted affinity-enhancing
    mutations (&gt;1.5-fold enrichment according to deep mutational scanning) and the true-negative
    rate (TNR) as the proportion of correctly predicted deleterious ones (enrichment ratio &lt;1).
    The resulting phase space of (PSSM, ΔΔ<em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">G</em>) thresholds revealed an expected tradeoff,
    wherein high TNR came at the cost of low TPR, and <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">vice versa</em> (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g003" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 3A</a></strong>). The likelihood of obtaining a
    multipoint mutant without a single deleterious mutation can be roughly approximated by TNR<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript"><em itemscope=""
        itemtype="http://schema.stenci.la/Emphasis">n</em></sup>, where <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">n</em> is the number of mutations. Given the large
    size of the vL-vH interface (20–30 positions [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref044">44</a></cite>]), we
    aimed for a large maximum number of mutations in each multipoint mutant (<em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">n</em> = 10) and therefore selected a stringent
    cutoff TNR = 94%, providing a rough estimate that 50% of designs with ten mutations would not
    contain a single deleterious mutation (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g003" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 3B</a></strong>). At this high TNR, the TPR is
    only 40%, reflecting the challenging tradeoff in the design of multipoint variants. We
    anticipate that in certain applications, such as in the design of improved antibodies for
    therapeutic application, a smaller number of mutations may be preferred. In such cases, a lower
    TNR and therefore a higher TPR may be implemented, and <strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g003" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 3C</a></strong> provides a guide for choosing
    different (PSSM, ΔΔ<em itemscope="" itemtype="http://schema.stenci.la/Emphasis">G</em>)
    thresholds. Instructions for computing a mutation-tolerance map based on any structure of an
    antibody Fv are available as Supplemental Data, and the AbLIFT web server enables user control
    of these parameters.</p>
  <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pcbi-1007207-g003"
    title="Fig 3"><img src="/thema/examples/articleAntibodies.html.media/g003.png" alt="" itemscope=""
      itemtype="http://schema.org/ImageObject">
    <figcaption>
      <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
        id="mutational-tolerance-mapping-by-rosetta-atomistic-energy-calculations-δδg-and-evolutionary-conservation-scores-pssm">
        Mutational-tolerance mapping by Rosetta atomistic energy calculations (ΔΔ<em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">G</em>) and evolutionary-conservation scores
        (PSSM).</h4>
      <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">a</strong>) Systematic analysis of combinations
        of PSSM and ΔΔ<em itemscope="" itemtype="http://schema.stenci.la/Emphasis">G</em> thresholds
        reveals an expected tradeoff in prediction accuracy of mutational tolerance. Each
        combination of thresholds (-10≤PSSM≤10; -10≤ΔΔ<em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">G</em>≤20 Rosetta energy units, R.e.u.)
        results in a different fraction of correctly predicted enhancing or deleterious mutations
        (true-positive rate [TPR] and true-negative rate [TNR], respectively) observed in the deep
        mutational scanning data of D44.1. (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">b</strong>) All (PSSM, ΔΔ<em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">G</em>) combinations are plotted with their
        TPR and TNR values, and the Pareto-optimal front is indicated in orange. Several
        combinations of (PSSM, ΔΔ<em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">G</em>) thresholds are indicated by blue
        triangles. (<strong itemscope="" itemtype="http://schema.stenci.la/Strong">c</strong>) The
        thresholds (PSSM≥-1, ΔΔ<em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">G</em>≤+1 R.e.u.) result in a TNR of 94% and
        TPR of 40% and were used in subsequent design calculations. Optimal ΔΔ<em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">G</em> cutoffs may vary depending on the
        energy function and the relaxation protocol. For details on these choices, see <a
          href="#sec007" itemscope="" itemtype="http://schema.stenci.la/Link">Methods</a>.</p>
    </figcaption>
  </figure>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec005">Automated affinity and
    stability design in the vL-vH interface</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">We next sought to develop a general
    and fully automated design protocol for improving molecular interactions across the vL-vH
    interface. AbLIFT starts by computing a mutational-tolerance map at the vL-vH interface using
    the approach described above; it then exhaustively enumerates the multipoint combinations of
    tolerated mutations; ranks them by energy, and selects low-energy variants for experimental
    testing. This algorithm resembles our recently described FuncLib method for designing
    functionally diverse enzyme repertoires [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref041">41</a></cite>], with
    the key differences that AbLIFT is applied to the core of obligatory binding surfaces rather
    than to solvent-exposed surfaces and most importantly, AbLIFT does not require an initial design
    round of protein stabilization.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">To validate AbLIFT, we chose two
    antibodies as subjects for design: the synthetic antibody G6, which targets human
    Vascular-Endothelial Growth Factor (VEGF) [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref045">45</a></cite>], and an
    engineered variant of the 492.1 antibody, designated h492.1, which targets human Quiescin
    Sulfhydryl Oxidase 1 (QSOX1). QSOX1 is a multi-domain disulfide-catalyst that is overproduced in
    tumors [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref046">46</a></cite>] and is a potential drug target [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref047">47</a></cite>,<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref048">48</a></cite>]. These
    antibodies are unrelated to D44.1 or to one another and are the products of protein engineering.
    G6 is widely used in animal studies and resulted from a phage-displayed synthetic Fab library of
    the light chain with a heavy chain sequence of an anti-mVEGF antibody (<em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">K</em><sub itemscope=""
      itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
        itemtype="http://schema.stenci.la/Emphasis">D</em></sub> approximately 1 nM) [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref049">49</a></cite>]. The h492.1 antibody was obtained by fusing the
    variable domains from the high-affinity (<em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">K</em><sub itemscope=""
      itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
        itemtype="http://schema.stenci.la/Emphasis">D</em></sub> approximately 1 nM)
    QSOX1-inhibiting murine antibody 492.1 onto a human IgG scaffold. Following this fusion, h492.1
    could not be expressed to detectable levels in a recombinant cultured human cell system,
    frustrating its further development. Thus, with these two targets, we sought to test the ability
    of AbLIFT to optimize high-affinity antibodies that resulted from conventional
    antibody-engineering procedures, whether well-behaved ones (G6) or ones that showed low (or no)
    detectable expression levels (h492.1).</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The computed mutational-tolerance map
    of G6 (starting from its bound structure, PDB entry 2FJG) at 30 vL-vH interface positions
    defined 26 affinity-enhancing mutations at 11 positions. To achieve significant improvement of
    vL-vH interface packing, we sought to design multipoint mutants with 4–10 mutations relative to
    G6, resulting in a tolerated sequence space of 203,835 unique multipoint mutants. All multipoint
    mutants were modeled in Rosetta, including by a backbone and side-chain minimization step, which
    is essential for enabling cavity-filling small-to-large mutations [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref050">50</a></cite>,<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref051">51</a></cite>], and the models were then ranked by energy. 53%
    of the mutants (&gt;100,000) exhibited energies as favorable as or better than the G6-bound
    antibody. Therefore, although the exhaustive enumeration of this large number of mutants is
    computationally demanding (approximately 6,000-CPU hours), the very large number of potentially
    improved designs makes a compelling case for exhaustive enumeration and ranking of variants
    within the tolerated sequence space. Furthermore, the computed mutational-tolerance map focuses
    exhaustive enumeration on a subset of stable multipoint mutants within the vast hypothetical
    sequence space of mutants at the vL-vH interface (20<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">30</sup> = 10<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">39</sup> unique sequences), &gt;99% of which
    are predicted to have reduced stability compared to the parental antibody (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s003" itemscope=""
        itemtype="http://schema.stenci.la/Link">S3 Fig</a></strong>).</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">We clustered the designs, eliminating
    ones that had fewer than four mutations relative to one another and selected the 18
    lowest-energy ones for experimental testing. The designs were formatted as scFvs, and their
    binding signals relative to the G6 antibody were first qualitatively measured at 8 nM VEGF
    concentration using yeast display [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref003">3</a></cite>] (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g004" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 4A</a></strong>). Encouragingly, seven designs
    (approximately 40%) showed comparable or higher binding signal at this concentration. The best
    two designs, G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des1</sup> and
    G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup>, were expressed
    as Fabs. When subjected to Ni-NTA purification, G6 exhibited multiple bands, indicative of
    sample heterogeneity, whereas, remarkably, both designs eluted mostly in the size expected for a
    Fab (<strong itemscope="" itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s004"
        itemscope="" itemtype="http://schema.stenci.la/Link">S4A and S4B Fig</a></strong>) [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref052">52</a></cite>].</p>
  <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pcbi-1007207-g004"
    title="Fig 4"><img src="/thema/examples/articleAntibodies.html.media/g004.png" alt="" itemscope=""
      itemtype="http://schema.org/ImageObject">
    <figcaption>
      <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
        id="fully-automated-antibody-stability-and-affinity-optimization-using-ablift">Fully
        automated antibody stability and affinity optimization using AbLIFT.</h4>
      <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">a</strong>) G6 and 18 low-energy designs, each
        encoding 4–10 mutations relative to G6 (number of mutations is indicated above the bars)
        were tested for binding using yeast display at 8 nM VEGF concentration, resulting in seven
        designs that showed comparable or higher binding signal compared to G6. G6<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des1</sup> and G6<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des13</sup> were chosen for further
        characterization (colored in blue and orange, respectively). (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">b</strong>) SPR kinetic analysis of VEGF binding
        with twofold dilutions from a maximal concentration of 100 nM by G6, G6<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des1</sup>, and G6<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des13</sup> Fabs demonstrated faster
        binding on-rate in the designs (<em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">k</em><sub itemscope=""
          itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">a</em></sub> = 2.3 * 10<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">5</sup> M<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>, 3.27 * 10<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">5</sup> M<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup> and 5.3 * 10<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">5</sup> M<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup>, respectively). G6<sup
          itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup> also improved
        binding off-rate (<em itemscope="" itemtype="http://schema.stenci.la/Emphasis">k</em><sub
          itemscope="" itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">d</em></sub> = 3.2 * 10<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">−5</sup> s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup> compared to 6 * 10<sup
          itemscope="" itemtype="http://schema.stenci.la/Superscript">−5</sup> s<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">-1</sup> in G6), resulting in an improved
        dissociation constant (<em itemscope=""
          itemtype="http://schema.stenci.la/Emphasis">K</em><sub itemscope=""
          itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">D</em></sub> = 60 pM compared to 270 pM in
        G6). (<strong itemscope="" itemtype="http://schema.stenci.la/Strong">c &amp; d</strong>)
        Thermal denaturation and temperature of aggregation onset experiments, respectively, using
        microscale thermophoresis indicated substantially higher apparent stability in the designs.
        (<strong itemscope="" itemtype="http://schema.stenci.la/Strong">e</strong>) Computational
        mutation-tolerance mapping indicated 11 positions at the vL-vH interface of the anti-VEGF
        antibody G6 (spheres) with potentially tolerated mutations. Thumbnails indicate selected
        mutations in a model structure of G6<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des13</sup> relative to G6 (gray). (<strong
          itemscope="" itemtype="http://schema.stenci.la/Strong">f</strong>) Expression levels in
        HEK293 cells of G6 and the designs formatted as IgG were measured using Western blot
        analysis showing approximately an order of magnitude improvement in IgG expression levels
        for the designs. <strong itemscope="" itemtype="http://schema.stenci.la/Strong">(g)</strong>
        Native mass-spectrometry analysis exhibited higher tolerance to applied collision energy in
        G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup> compared to
        G6, both formatted as IgG. The error bars represent standard deviations inferred from three
        repeats.</p>
    </figcaption>
  </figure>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Next, the designs’ affinities for
    VEGF were determined using SPR (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g004" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 4B</a></strong>). Both designs improved binding
    on-rate, and G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup> also
    improved the off-rate, resulting in fivefold improvement in <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">K</em><sub itemscope=""
      itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
        itemtype="http://schema.stenci.la/Emphasis">D</em></sub> relative to G6. Both designs also
    exhibited substantial improvements in thermal stability and the temperature of aggregation onset
    (19° C and 10° C, respectively) (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g004" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 4C and 4D</a></strong>). We examined the model
    structure of G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup>,
    which comprised six mutations at the vL-vH interface relative to G6, finding that the mutations
    were likely to improve the interface through backbone rigidification and the introduction of a
    new buried polar hydrogen-bond network (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g004" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 4E</a></strong>). Such cooperative interaction
    networks do not typically arise in conventional antibody affinity-maturation processes (either
    in nature or the laboratory), which select mutations in a stepwise manner and are therefore
    biased towards additive rather than cooperative multipoint mutations. Introducing accurate new
    polar interaction networks is also a fundamental challenge for computational design [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref053">53</a></cite>,<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref054">54</a></cite>] and the
    use of evolutionary constraints during design has recently been shown to overcome this challenge
    [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref042">42</a></cite>].</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">We next tested the stability and
    expressibility of the VEGF designs formatted as full-length IgGs. We expressed G6, G6<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des1</sup>, and G6<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup> in HEK293 cells and
    found that the designs exhibited nearly an order of magnitude higher expression level than G6
    (<strong itemscope="" itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g004"
        itemscope="" itemtype="http://schema.stenci.la/Link">Fig 4F</a></strong>). We next measured
    the relative stabilities of G6 and G6<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des13</sup> using native mass spectrometry
    [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref055">55</a></cite>] under reducing conditions by titrating the
    collision energy (<strong itemscope="" itemtype="http://schema.stenci.la/Strong"><a
        href="#pcbi-1007207-g004" itemscope="" itemtype="http://schema.stenci.la/Link">Fig
        4G</a></strong>). We found that G6 IgG disassembly started at lower collision energy
    compared to G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup>,
    indicative of the design’s higher stability (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s005" itemscope=""
        itemtype="http://schema.stenci.la/Link">S5 Fig</a></strong>). We, therefore, concluded that
    AbLIFT could substantially improve expressibility, stability, and affinity, regardless of
    whether the antibody was formatted as Fab or IgG.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">We applied the same computational
    strategy to h492.1, in which the Fv was derived from a murine antibody and the constant regions
    were derived from human IgG1. Since h492.1 failed to show detectable expression in HEK293 cell
    cultures, we started the computational design from the structure of the murine 492.1 parental
    antibody in complex with QSOX1 (PDB entry: 4IJ3) [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref047">47</a></cite>]. We
    selected the 20 lowest-energy, sequence-clustered AbLIFT designs, fused them to human IgG1
    constant domains and subjected them to HEK293-expression screening from crude cell lysate
    supernatant. Dot-blot analysis showed detectable expression levels for all 20 designs, in clear
    contrast with the lack of detectable expression for h492.1 (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g005" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 5A</a></strong>). We further quantitated
    expression levels using Western blot, revealing substantial variation in the expression levels
    among the designs (<strong itemscope="" itemtype="http://schema.stenci.la/Strong"><a
        href="#pcbi-1007207-g005" itemscope="" itemtype="http://schema.stenci.la/Link">Fig
        5B</a></strong>). In parallel, we examined the levels of QSOX1 inhibition by the 20 designs,
    finding that 50% showed high levels of QSOX1 inhibition (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s006" itemscope=""
        itemtype="http://schema.stenci.la/Link">S6 Fig</a></strong>). Based on activities and
    expression levels, we selected h492.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des3</sup> and h492.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des18</sup> for further analysis. These designs
    were purified and added to QSOX1 activity assays to test for inhibition. h492.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des18</sup> showed comparable inhibitory levels
    to the murine parent antibody when provided at equimolar amounts to a typical physiological
    concentration of QSOX1 (25 nM) as found in human serum (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-g005" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 5C</a></strong>) [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref056">56</a></cite>]. This
    analysis demonstrated that h492.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des18</sup> almost completely recovered the
    activity of the parental antibody while gaining high expression levels (approximately 75 mg/L
    supernatant). Structural analysis indicated that this design improved packing at the vL-vH
    interface (<strong itemscope="" itemtype="http://schema.stenci.la/Strong"><a
        href="#pcbi-1007207-g005" itemscope="" itemtype="http://schema.stenci.la/Link">Fig
        5D</a></strong>), demonstrating that in some cases optimizing this region could have a
    dramatic effect on the expression levels of engineered antibodies.</p>
  <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pcbi-1007207-g005"
    title="Fig 5"><img src="/thema/examples/articleAntibodies.html.media/g005.png" alt="" itemscope=""
      itemtype="http://schema.org/ImageObject">
    <figcaption>
      <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
        id="substantial-increase-in-antibody-expression-yields-following-ablift-design">Substantial
        increase in antibody expression yields following AbLIFT design.</h4>
      <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">a</strong>) Dot blot analysis showed no
        detectable expression for h492.1 in HEK293 cells, whereas all 20 designs showed detectable
        levels of expression. (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">b</strong>) Relative expression levels of the 20
        designs using Western blot analysis. h492.1<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des3</sup> and h492.1<sup itemscope=""
          itemtype="http://schema.stenci.la/Superscript">des18</sup> showed high expression and were
        selected for further analysis. (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">c</strong>) QSOX1 inhibitory activity assay
        using the parental 492.1 antibody and two designs. The inhibitory activity was measured for
        each antibody in a sulfhydryl oxidase assay using a physiological concentration of QSOX1 (25
        nM). h492.1<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des18</sup>
        showed comparable inhibitory activity relative to the parental antibody, with only a slight
        decrease when provided at sub-stoichiometric amounts (10 nM). (<strong itemscope=""
          itemtype="http://schema.stenci.la/Strong">d</strong>) The structural context of mutations
        in h492.1<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des18</sup>
        (color) relative to the experimental structure of 492.1 (gray). Spheres indicate the
        locations of the mutations, and the thumbnail shows two of the four designed mutations,
        which improve interchain packing and rigidify the backbone at the vL-vH interface according
        to the model structure.</p>
    </figcaption>
  </figure>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Finally, we asked whether there were
    any sequence features in common among the designs (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s009" itemscope=""
        itemtype="http://schema.stenci.la/Link">S3</a> and <a href="#pcbi-1007207-s010" itemscope=""
        itemtype="http://schema.stenci.la/Link">S4</a> Tables</strong>). Strikingly, position 43<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">L</sup> (Chothia numbering) was
    mutated to Pro in D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> and in &gt;60% of the G6 and h492.1
    designs. Position 43<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">L</sup> is
    located in a tight turn that connects two neighboring β strands, away from the CDRs, but Pro is
    not the consensus identity at this position (Ala and Ser are preferred). Furthermore, mutations
    at this position may have an important effect on the rigid-body angle formed by the variable
    light and heavy domains [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref044">44</a></cite>,<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref057">57</a></cite>], and it
    is, therefore, unlikely that this mutation would universally improve antibody stability and
    affinity. Other than this mutation to Pro, we did not observe common sequence features among the
    designs. Overlapping but non-identical sets of positions were varied in each of the three case
    studies presented here, and the mutations at aligned positions were dissimilar. We, therefore,
    concluded that the designs improved interactions across the vL-vH interface through a variety of
    mechanisms that depended on the specific molecular structure of the parental antibodies.</p>
  <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec006">Discussion</h2>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Our study demonstrates that improved
    interactions across the vL-vH interface may result in substantial optimization of a range of
    essential parameters for antibody development, including expressibility, stability, and
    affinity. The automated AbLIFT strategy enables the design of cooperative networks of multipoint
    mutations in the antibody core that are likely to be inaccessible to experimental affinity
    maturation processes since these latter methods select mutations in a stepwise manner. Since
    AbLIFT impacts the antibody core and does not alter the structure of the antigen-binding site,
    the designed mutations cooperate with surface mutations identified through conventional
    antibody-engineering processes to further increase affinity and stability. AbLIFT may be
    particularly beneficial in antibodies, such as G6 and h492.1, which were the product of
    antibody-engineering approaches that might compromise antibody structural integrity, resulting
    in reduced affinity or stability. Moreover, antibody structure-prediction methods now often
    produce atomically accurate models at the vL-vH interface (though still not at the CDR H3)
    [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref058">58</a></cite>–<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref060">60</a></cite>],
    suggesting that by restricting design to the framework regions, AbLIFT may in some cases enable
    antibody optimisation even in the absence of an experimental structure. We note, however, that
    AbLIFT considers only phylogenetic information and molecular energetics and disregards
    immunogenicity, which may be an important consideration in antibodies developed for clinical
    use. To address this concern, the AbLIFT web server enables complete control over the design
    sequence space and can be used to eliminate mutations with immunogenic potential.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The surprisingly broad ability of
    vL-vH design to optimize antibody properties is consistent with the Colman interface-adaptor
    hypothesis, according to which the formation of the Fv from two chains renders it flexible
    [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref034">34</a></cite>]. According to this hypothesis, Fv flexibility is
    likely to be an adaptive property selected by evolution to broaden molecular recognition by each
    individual antibody to a range of antigens through induced fit or conformational selection
    [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref061">61</a></cite>], thereby solving the conundrum of how a large but
    finite antibody repertoire could recognize a potentially infinite range of antigens [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref062">62</a></cite>]. Flexibility, however, might come at a cost,
    since an Fv that exhibits flexible vL-vH pairing may occupy multiple molecular states that
    compete with the binding-competent state, thus lowering antigen-binding affinity. Flexibility
    may moreover result in misfolding or transient dissociation of the two variable chains,
    resulting in terminal aggregation or degradation by the cellular proteostasis machinery, thereby
    lowering expression yields. In extreme cases, poorly defined packing at the vL-vH interface can
    lead to substantial rearrangements of the antibody variable domain during binding [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref063">63</a></cite>], and such rearrangements could lower
    antigen-binding affinity and specificity. Therefore, while the interface-adaptor hypothesis
    neatly explains why flexibility at the vL-vH interface is advantageous in early steps of
    antibody selection, broad specificity and marginal vL-vH interface stability become liabilities
    in later stages of antibody development into research or therapeutic tools. We anticipate that
    AbLIFT will have a wide scope to automatically and reliably improve stability, solubility,
    expressibility, affinity, and structural integrity in numerous antibodies in which these
    important properties are compromised.</p>
  <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec007">Methods</h2>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec008">D44.1 genetic library
    construction</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Forward and reverse primers with the
    degenerate codon NNS were generated for all 135 positions on the Fv of D44.1, essentially as
    described [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref064">64</a></cite>]. Primers were ordered from Sigma (Sigma-Aldrich,
    Rehovot, Israel) and were used to introduce all possible amino acids per position by QuickChange
    mutagenesis [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref065">65</a></cite>]. Next, the PCR product of each position was
    transformed into yeast (EBY100 cells) and plated on SD-Trp as described [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref066">66</a></cite>].
    Briefly, plates with more than 400 colonies were scraped with 1 ml SDCAA, 50 μl was added to 5
    ml SDCAA tube and cells were then grown at 30°C overnight. The point mutants were split into six
    libraries, corresponding to positions that were at most 130 bp apart from one another to enable
    deep mutational scanning using 150 bp reads.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec009">Yeast surface display
    selection for libraries</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Yeast-display experiments were
    conducted essentially as described [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref003">3</a></cite>]. Briefly,
    yeast cells were grown in selective medium SDCAA overnight at 30°C. The cells were then
    resuspended in 10 ml induction medium and incubated at 20°C for 20 h. 10<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">7</sup> cells were then used for yeast-cell
    surface display experiments: cells were subjected to primary antibody (mouse monoclonal IgG1
    anti-c-Myc (9E10) sc-40, Santa Cruz Biotechnology) for expression monitoring and biotinylated
    ligand at 90 nM lysozyme (GeneTex) in PBS-F for 30 min at room temperature. The cells then
    underwent a second staining with fluorescently labeled secondary antibody
    (AlexaFluor488—goat-anti-mouse IgG1 (Life Technologies) for scFv labeling, Streptavidin-APC
    (SouthernBiotech) for ligand labeling) for 10 min at 4°C. Next, the cell fluorescence was
    measured and cells were collected under sorting conditions for expression and top 15% binders.
    The selection gates were calibrated using the wild-type scFv D44.1 and these gates were
    subsequently applied to the library constructs. Following fluorescence-activated cell sorting
    (FACS), cells were grown in SDCAA for 1–2 days and plasmids were extracted using Zymoprep Yeast
    Plasmid Miniprep II kit (Zymo Research).</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec010">Yeast surface display of
    anti-VEGF scFvs</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">18 designs of improved binding
    affinity antibodies against VEGF and the wild-type G6 Fvs were ordered from Twist Biosciences as
    scFvs. These, as described above, were amplified by PCR and cloned into pCTCon2 using homologous
    recombination in yeast [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref066">66</a></cite>]. The plasmids were extracted by Zymoprep kit II,
    transformed into bacteria for sequence validation and verified clones were transformed to yeast
    for display [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref003">3</a></cite>]. The wild-type and designed antibodies were tested
    for binding by flow cytometry with 8 nM biotinylated VEGF (Recombinant Human VEGF 165,
    Biotinylated Protein R&amp;D systems).</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec011">DNA preparation for deep
    sequencing</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">To connect the DNA adaptors for deep
    sequencing, the plasmids extracted from the libraries were amplified using Phusion High-Fidelity
    DNA Polymerase (ThermoFisher) in a two-step PCR protocol.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">PCR 1:</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(barcode:
    CTCTTTCCCTACACGACGCTCTTCCGATCT)</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;forward (seg1):<strong
      itemscope=""
      itemtype="http://schema.stenci.la/Strong">&lt;barcode&gt;</strong>AGGGTCGGCTAGCCATATG</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;forward (seg2):<strong
      itemscope=""
      itemtype="http://schema.stenci.la/Strong">&lt;barcode&gt;</strong>GGATCGAATGGGTTAAACAACGT</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;forward (seg3):<strong
      itemscope=""
      itemtype="http://schema.stenci.la/Strong">&lt;barcode&gt;</strong>ACACCTCCTCTAACACCGC</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;forward (seg4):<strong
      itemscope=""
      itemtype="http://schema.stenci.la/Strong">&lt;barcode&gt;</strong>CTGGTGGCGGTGGCTC</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;forward (seg5):<strong
      itemscope=""
      itemtype="http://schema.stenci.la/Strong">&lt;barcode&gt;</strong>GCCGTGCGTCTCAGTCTATT</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;forward (seg6): <strong
      itemscope=""
      itemtype="http://schema.stenci.la/Strong">&lt;barcode&gt;</strong>CCATCTCGTTTCTCCGGC</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;reverse: <strong itemscope=""
      itemtype="http://schema.stenci.la/Strong">CTGGAGTTCAGACGTGTGCTCTTCCGATCT</strong>GGATCGAATGGGTTAAACAACGT
  </p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The PCR product for each population
    (expressed and top 15% of binders for each of the six libraries) was cleaned using Agencourt
    AMPure XP (Beckman Coulter, Inc.) and 1 μl from a 1:10 dilution was taken to the next PCR step
    for index labeling using KAPA Hifi DNA-polymerase (Kapa Biosystems, London, England):</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;forward:
    AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">&gt;reverse:
    CAAGCAGAAGACGGCATACGAGAT&lt;index&gt;GTGACTGGAGTTCAGACGTGTGC</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Top 15%—index: CAATAGTC</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Expressed—index: TTGAGCCT</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">All the primers were ordered as
    PAGE-purified oligos. The concentration of the PCR product was measured using Qu-bit assay (Life
    Technologies, Grand Island, New York).</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec012">Deep-sequencing runs</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">DNA samples were run on an Illumina
    MiSeq using 150-bp paired-end kits. The FASTQ sequence files were obtained for each run, and
    customized scripts were used to generate the selection heat maps from the data as previously
    described [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref064">64</a></cite>]. Briefly, the script starts by translating the
    DNA sequence to amino acid sequence; eliminates sequences that harbor more than one amino acid
    mutation relative to wild type and also sequences that failed the QC test; counts each variant
    in each population; and eliminates variants with fewer than 100 counts in the reference
    population (to reduce statistical uncertainty).</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec013">Sequencing analysis</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">To derive the mutational landscapes
    we compute the frequency <em itemscope="" itemtype="http://schema.stenci.la/Emphasis">P<sup
        itemscope="" itemtype="http://schema.stenci.la/Superscript">i,j</sup></em> of each mutant
    relative to wild-type in the selected and reference pools, where <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">i</em> is the position and <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">j</em> is the substitution, relative to wild-type:
  </p><span itemscope="" itemtype="http://schema.stenci.la/MathBlock"><span
      class="mjx-chtml MJXc-display" style="text-align: center;"><span id="M1" class="mjx-math"
        aria-label="Equation"><span class="mjx-mrow" aria-hidden="true"><span class="mjx-msup"><span
              class="mjx-base" style="margin-right: -0.109em;"><span class="mjx-mrow"><span
                  class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.446em; padding-bottom: 0.298em; padding-right: 0.109em;">P</span></span></span></span><span
              class="mjx-sup"
              style="font-size: 70.7%; vertical-align: 0.584em; padding-left: 0.271em; padding-right: 0.071em;"><span
                class="mjx-mrow" style=""><span class="mjx-mi"><span
                    class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.446em; padding-bottom: 0.298em;">i</span></span><span
                  class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                    style="margin-top: -0.144em; padding-bottom: 0.519em;">,</span></span><span
                  class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.446em; padding-bottom: 0.519em;">j</span></span></span></span></span><span
            class="mjx-mo MJXc-space3"><span class="mjx-char MJXc-TeX-main-R"
              style="padding-top: 0.077em; padding-bottom: 0.298em;">=</span></span><span
            class="mjx-mfrac MJXc-space3"><span class="mjx-box MJXc-stacked"
              style="width: 5.858em; padding: 0px 0.12em;"><span class="mjx-numerator"
                style="width: 5.858em; top: -1.529em;"><span class="mjx-mrow"><span
                    class="mjx-msup"><span class="mjx-base"><span class="mjx-mrow"><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.151em; padding-bottom: 0.372em;">c</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.151em; padding-bottom: 0.372em;">o</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.151em; padding-bottom: 0.372em;">u</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.151em; padding-bottom: 0.372em;">n</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.298em; padding-bottom: 0.372em;">t</span></span></span></span><span
                      class="mjx-sup"
                      style="font-size: 70.7%; vertical-align: 0.519em; padding-left: 0px; padding-right: 0.071em;"><span
                        class="mjx-mrow" style=""><span class="mjx-mi"><span
                            class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.446em; padding-bottom: 0.298em;">i</span></span><span
                          class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                            style="margin-top: -0.144em; padding-bottom: 0.519em;">,</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.446em; padding-bottom: 0.519em;">j</span></span></span></span></span></span></span><span
                class="mjx-denominator" style="width: 5.858em; bottom: -1.009em;"><span
                  class="mjx-mrow"><span class="mjx-msub"><span class="mjx-base"><span
                        class="mjx-mrow"><span class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">c</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">o</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">u</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">n</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.372em; padding-bottom: 0.298em;">t</span></span></span></span><span
                      class="mjx-sub"
                      style="font-size: 70.7%; vertical-align: -0.219em; padding-right: 0.071em;"><span
                        class="mjx-mrow" style=""><span class="mjx-mi"><span
                            class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">w</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.446em; padding-bottom: 0.298em;">i</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.446em; padding-bottom: 0.298em;">l</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.446em; padding-bottom: 0.298em; padding-right: 0.003em;">d</span></span><span
                          class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.298em; padding-bottom: 0.446em;">−</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.372em; padding-bottom: 0.298em;">t</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.519em; padding-right: 0.006em;">y</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.446em;">p</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">e</span></span></span></span></span></span></span><span
                style="border-bottom: 1.3px solid; top: -0.296em; width: 5.858em;"
                class="mjx-line"></span></span><span
              style="height: 2.537em; vertical-align: -1.009em;"
              class="mjx-vsize"></span></span></span></span></span></span>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph"> where count is the number of reads
    for each mutant. The selection coefficients are then computed as the ratio: </p><span
    itemscope="" itemtype="http://schema.stenci.la/MathBlock"><span class="mjx-chtml MJXc-display"
      style="text-align: center;"><span id="M2" class="mjx-math" aria-label="Equation"><span
          class="mjx-mrow" aria-hidden="true"><span class="mjx-msup"><span class="mjx-base"
              style="margin-right: -0.032em;"><span class="mjx-mrow"><span class="mjx-mi"><span
                    class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.519em; padding-bottom: 0.298em; padding-right: 0.032em;">S</span></span></span></span><span
              class="mjx-sup"
              style="font-size: 70.7%; vertical-align: 0.584em; padding-left: 0.13em; padding-right: 0.071em;"><span
                class="mjx-mrow" style=""><span class="mjx-mi"><span
                    class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.446em; padding-bottom: 0.298em;">i</span></span><span
                  class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                    style="margin-top: -0.144em; padding-bottom: 0.519em;">,</span></span><span
                  class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.446em; padding-bottom: 0.519em;">j</span></span></span></span></span><span
            class="mjx-mo MJXc-space3"><span class="mjx-char MJXc-TeX-main-R"
              style="padding-top: 0.077em; padding-bottom: 0.298em;">=</span></span><span
            class="mjx-mfrac MJXc-space3"><span class="mjx-box MJXc-stacked"
              style="width: 5.689em; padding: 0px 0.12em;"><span class="mjx-numerator"
                style="width: 5.689em; top: -1.724em;"><span class="mjx-mrow"><span
                    class="mjx-msub"><span class="mjx-base"><span class="mjx-mrow"><span
                          class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.446em; padding-bottom: 0.593em;">(</span></span><span
                          class="mjx-msup"><span class="mjx-base"
                            style="margin-right: -0.109em;"><span class="mjx-mrow"><span
                                class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                                  style="padding-top: 0.446em; padding-bottom: 0.298em; padding-right: 0.109em;">P</span></span></span></span><span
                            class="mjx-sup"
                            style="font-size: 70.7%; vertical-align: 0.513em; padding-left: 0.271em; padding-right: 0.071em;"><span
                              class="mjx-mrow" style=""><span class="mjx-mi"><span
                                  class="mjx-char MJXc-TeX-math-I"
                                  style="padding-top: 0.446em; padding-bottom: 0.298em;">i</span></span><span
                                class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                                  style="margin-top: -0.144em; padding-bottom: 0.519em;">,</span></span><span
                                class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                                  style="padding-top: 0.446em; padding-bottom: 0.519em;">j</span></span></span></span></span><span
                          class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.446em; padding-bottom: 0.593em;">)</span></span></span></span><span
                      class="mjx-sub"
                      style="font-size: 70.7%; vertical-align: -0.439em; padding-right: 0.071em;"><span
                        class="mjx-mrow" style=""><span class="mjx-mi"><span
                            class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">s</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">e</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.446em; padding-bottom: 0.298em;">l</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">e</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">c</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.372em; padding-bottom: 0.298em;">t</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">e</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.446em; padding-bottom: 0.298em; padding-right: 0.003em;">d</span></span></span></span></span></span></span><span
                class="mjx-denominator" style="width: 5.689em; bottom: -1.288em;"><span
                  class="mjx-mrow"><span class="mjx-msub"><span class="mjx-base"><span
                        class="mjx-mrow"><span class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.446em; padding-bottom: 0.593em;">(</span></span><span
                          class="mjx-msup"><span class="mjx-base"
                            style="margin-right: -0.109em;"><span class="mjx-mrow"><span
                                class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                                  style="padding-top: 0.446em; padding-bottom: 0.298em; padding-right: 0.109em;">P</span></span></span></span><span
                            class="mjx-sup"
                            style="font-size: 70.7%; vertical-align: 0.409em; padding-left: 0.271em; padding-right: 0.071em;"><span
                              class="mjx-mrow" style=""><span class="mjx-mi"><span
                                  class="mjx-char MJXc-TeX-math-I"
                                  style="padding-top: 0.446em; padding-bottom: 0.298em;">i</span></span><span
                                class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                                  style="margin-top: -0.144em; padding-bottom: 0.519em;">,</span></span><span
                                class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                                  style="padding-top: 0.446em; padding-bottom: 0.519em;">j</span></span></span></span></span><span
                          class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                            style="padding-top: 0.446em; padding-bottom: 0.593em;">)</span></span></span></span><span
                      class="mjx-sub"
                      style="font-size: 70.7%; vertical-align: -0.439em; padding-right: 0.071em;"><span
                        class="mjx-mrow" style=""><span class="mjx-mi"><span
                            class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">r</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">e</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.519em; padding-bottom: 0.519em; padding-right: 0.06em;">f</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">e</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">r</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">e</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">n</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">c</span></span><span
                          class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                            style="padding-top: 0.225em; padding-bottom: 0.298em;">e</span></span></span></span></span></span></span><span
                style="border-bottom: 1.3px solid; top: -0.296em; width: 5.689em;"
                class="mjx-line"></span></span><span
              style="height: 3.012em; vertical-align: -1.288em;"
              class="mjx-vsize"></span></span></span></span></span></span>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph"> where <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">selected</em> refers to the top 15% binding
    population and reference refers to the reference population (Expression). The resulting <em
      itemscope="" itemtype="http://schema.stenci.la/Emphasis">S<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">i,j</sup></em> values are then transformed to
    <em itemscope="" itemtype="http://schema.stenci.la/Emphasis">−ln</em> enrichment values: </p>
  <span itemscope="" itemtype="http://schema.stenci.la/MathBlock"><span
      class="mjx-chtml MJXc-display" style="text-align: center;"><span id="M3" class="mjx-math"
        aria-label="Equation"><span class="mjx-mrow" aria-hidden="true"><span class="mjx-mo"><span
              class="mjx-char MJXc-TeX-main-R"
              style="padding-top: 0.298em; padding-bottom: 0.446em;">−</span></span><span
            class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
              style="padding-top: 0.446em; padding-bottom: 0.298em;">l</span></span><span
            class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
              style="padding-top: 0.225em; padding-bottom: 0.298em;">n</span></span><span
            class="mjx-mo"><span class="mjx-char MJXc-TeX-size1-R"
              style="padding-top: 0.593em; padding-bottom: 0.593em;">(</span></span><span
            class="mjx-msup"><span class="mjx-base" style="margin-right: -0.032em;"><span
                class="mjx-mrow"><span class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.519em; padding-bottom: 0.298em; padding-right: 0.032em;">S</span></span></span></span><span
              class="mjx-sup"
              style="font-size: 70.7%; vertical-align: 0.584em; padding-left: 0.13em; padding-right: 0.071em;"><span
                class="mjx-mrow" style=""><span class="mjx-mi"><span
                    class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.446em; padding-bottom: 0.298em;">i</span></span><span
                  class="mjx-mo"><span class="mjx-char MJXc-TeX-main-R"
                    style="margin-top: -0.144em; padding-bottom: 0.519em;">,</span></span><span
                  class="mjx-mi"><span class="mjx-char MJXc-TeX-math-I"
                    style="padding-top: 0.446em; padding-bottom: 0.519em;">j</span></span></span></span></span><span
            class="mjx-mo"><span class="mjx-char MJXc-TeX-size1-R"
              style="padding-top: 0.593em; padding-bottom: 0.593em;">)</span></span></span></span></span></span>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec014">Computational methods</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">All Rosetta design simulations used
    git version fb77c732b4f08b6c30572a2ef7760ad3bb4535ca of the Rosetta biomolecular modeling
    software, which is freely available to academics at <a href="http://www.rosettacommons.org/"
      itemscope="" itemtype="http://schema.stenci.la/Link">http://www.rosettacommons.org</a>.
    Position-Specific Scoring Matrices (PSSM) for designed antibodies against VEGF (PDB: 2FJG) and
    against QSOX1 (PDB: 4IJ3) were collected as described in ref. [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref038">38</a></cite>] and are
    distributed with the Rosetta release. RosettaScripts [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref067">67</a></cite>] and
    command lines are available in Supplemental Data. As in the <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">AbDesign</em> method [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref038">38</a></cite>],
    separate PSSMs were generated for CDRs 3 and for CDRs 1, 2 and the framework by aligning
    structurally similar antibodies in the PDB and selecting only sequences that did not exhibit
    gaps relative to the query sequence; furthermore, a strict cutoff of ≤ 0.5 Å backbone-carbonyl
    rmsd was used to eliminate structurally divergent sequences. Thus, the PSSMs were only based on
    structural considerations and not on sequence homology or source organism.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">We refined each bound PDB structure
    by four iterations of side-chain packing and side-chain and backbone minimization, saving the
    minimum-energy structure. Computational mutation scanning was applied to the refined structure
    using the FilterScan filter in Rosetta [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref024">24</a></cite>]. At
    every position, each allowed mutation (that is, every amino acid identity with PSSM score ≥-1)
    was modeled singly against the background of the refined structure. Protein side chains within 8
    Å of the modeled mutation were repacked, and side-chain and constrained backbone minimization
    were used to accommodate the mutation. The energy difference between the refined structure and
    the optimized configuration of the single-point mutant was calculated using the talaris2014
    energy function [<cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref068">68</a></cite>]. The energy threshold used to define the
    tolerated mutation space was +1 R.e.u. We next enumerated all possible combinations of mutations
    against VEGF (203,835 models) and against QSOX1 (491,235 models), modeled them in Rosetta and
    relaxed them by sidechain packing and sidechain, backbone and rigid-body minimization with
    harmonic backbone coordinate restraints. Designs were ranked based on their energy and the top
    18 designs differing by 4–10 mutations relative to one another (VEGF) (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s008" itemscope=""
        itemtype="http://schema.stenci.la/Link">S2 Table</a></strong>) and the top 20 designs
    differing by 3–14 mutations relative to one another (QSOX1) (<strong itemscope=""
      itemtype="http://schema.stenci.la/Strong"><a href="#pcbi-1007207-s009" itemscope=""
        itemtype="http://schema.stenci.la/Link">S3 Table</a></strong>) were selected for
    experimental characterization.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec015">The AbLIFT web-server</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The web-server implements several
    improvements relative to the method used to design the G6 and h492.1 variants [<cite
      itemscope="" itemtype="http://schema.stenci.la/Cite"><a
        href="#pcbi-1007207-ref041">41</a></cite>]. In the AbLIFT web-server, the multiple-sequence
    alignment used to construct the PSSM is first filtered to eliminate all loops and
    secondary-structure elements that exhibit any gaps relative to the query sequence. Furthermore,
    the web-server implements more accurate atomistic scoring and enables greater user control: it
    uses the recent Rosetta energy function ref15 [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref069">69</a></cite>] with
    improved electrostatics and solvation potentials relative to the previous Rosetta energy
    function talaris and allows the user to manually modify the tolerated sequence space (for
    instance, based on prior experimental data or to eliminate potential immunogenic sequence
    signatures). Accordingly, ΔΔ<em itemscope="" itemtype="http://schema.stenci.la/Emphasis">G</em>
    and PSSM cutoffs may be different from those used to in the designs described in the paper, and
    the web server provides user control over these parameters.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec016">Bacterial expression and
    purification (D44.1 and D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup>)</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The design and wild-type were
    transformed into RH2.2 plasmid for expression as Fabs, where the heavy chain was N-terminally
    His-tagged and the light chain was expressed as a separate protein. Both chains contain a
    secretion sequence for direction to the periplasmic space, where they fold and dimerize.
    Restriction-free cloning was done using Kapa HiFi Hotstart Readymix (Kapa Biosystems) according
    to the manufacturer’s protocol.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Cells were induced with 1 mM IPTG at
    OD600 = 0.6, transferred to 20°C, and harvested after 20 h. The cells were then resuspended in
    buffer A [20 mM phosphate buffer pH 6.2, 150 mM NaCl] and sonicated. The supernatant was
    harvested by centrifugation (20,000 × <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">g</em>, 1 h), filtered, and loaded on HiTrap TALON
    crude 1 ml column (GE Healthcare). Then it was washed with 15–20 bed volumes of buffer A, and
    then eluted with buffer B [20 mM phosphate buffer pH 6.2,150 mM NaCl, 150 mM imidazole].
    Imidazole was removed from the eluate by dialysis against Buffer C [20 mM Hepes buffer pH 7,150
    mM NaCl] (1:400). The sample was then concentrated (Amicon Ultra-15 Centrifugal Filter; Merck)
    and purified by gel filtration in buffer C over a HiLoad 16/600 Superdex 200 pg column.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec017">Secreted IgG (G6, G6<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup>) and Fab (D44.1<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup>) production in
    suspension</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Antibodies were expressed in
    suspension-HEK293F cells, grown in FreeStyle medium (Gibco), in a shaking incubator (115 rpm),
    at 37°C, in a controlled environment of 8% CO<sub itemscope=""
      itemtype="http://schema.stenci.la/Subscript">2</sub>. The variable regions of the different
    heavy and light chains were cloned separately, upstream of IgG1 human Ab scaffolds, into p3BNC
    plasmids. Transfections were done using linear 40 kDa polyethyleneimine (PEI) (Polysciences) at
    3 mg of PEI per 1 mg of plasmid DNA per 1 L of culture, at a cell density of 1 million cells/ml.
    Growth media were collected after 5–7 days and separated from cells by centrifugation at 600 x
    g. Media were then supplemented with 0.02% (wt/vol) sodium azide and 0.1 mM PMSF and further
    clarified by centrifugation at 16,840 x g for 30 min.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec018">Fab production (D44.1, G6,
    G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des1</sup>, G6<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup>)</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Adherent HEK293T cells were
    cotransfected with genes encoding the light and heavy chain Fabs (heavy chain fused to
    C-terminal His tag) in p3BNC plasmids using linear PEI as a transfection reagent (12.5 μg/12.5
    μg/50 μg, respectively, per 15-cm plate). Seventy-two hours post-transfection, the medium
    containing the secreted protein was collected (~250 ml).</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec019">Fab purification (D44.1,
    D44.1<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup>, G6, G6<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des1</sup>, G6<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des13</sup>)</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The filtered medium was concentrated
    to ~200 ml using a diafiltration device (QuixStand Benchtop System; GE Healthcare). The medium
    composition was exchanged to buffer A [50 mM Tris pH 8 and 150 mM NaCl] using the same device.
    This was loaded on a HisTrap HP 5 ml column (GE Healthcare). Washed with 15 bed volumes of 20 mM
    Tris pH 8, 150 mM NaCl and 10mM imidazole and was eluted with 20 mM Tris pH 8, 150 mM NaCl and
    250 mM imidazole. Imidazole was removed from the eluate by dialysis against Buffer A (1:400).
    The sample was then concentrated (Amicon Ultra-15 Centrifugal Filter; Merck) and purified by gel
    filtration in buffer A over a HiLoad 16/600 Superdex 200 pg column.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec020">Apparent <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">T</em><sub itemscope=""
      itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
        itemtype="http://schema.stenci.la/Emphasis">m</em></sub> and aggregation onset measurements
  </h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The apparent melting temperature of
    the antibodies was determined by Prometheus NT. Plex instrument (NanoTemper Technologies), a
    label-free method. Fabs obtained from secreted Fab production in adherent cells (D44.1, G6,
    G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des1</sup>, G6<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup>) and from production
    in suspension (D44.1<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup>)
    were diluted to 0.2 mg/ml (in 20 mM Hepes pH 7 and 50mM NaCl for anti-lysozyme antibodies and in
    20 mM Hepes pH 7.5, 150 mM NaCl for anti VEGF antibodies). The temperature was ramped from 25°C
    to 100°C at 0.05°C/s, and both <em itemscope=""
      itemtype="http://schema.stenci.la/Emphasis">T</em><sub itemscope=""
      itemtype="http://schema.stenci.la/Subscript"><em itemscope=""
        itemtype="http://schema.stenci.la/Emphasis">m</em></sub> and aggregation-onset temperature
    were measured.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec021">Surface-plasmon resonance
  </h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Surface plasmon resonance experiments
    on the anti-lysozyme (D44.1 and D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup> expressed in bacteria) and anti-VEGF
    antibodies (G6, G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des1</sup>
    and G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup> expressed in
    adherent cells) were carried out on a Biacore T200 instrument (GE Healthcare) at 25°C with HBS-N
    EP+ [10 mM Hepes, 150 mM NaCl, 3 mM EDTA, 0.005% vol/vol surfactant P20 (pH 7.4)]. For binding
    analysis, 1,000–1,600 response units (RU) of Fab were captured on a CM5 sensor chip. Samples of
    different protein concentrations were injected over the surface at a flow rate of 30 μL/min for
    240 s, and the chip was washed with buffer for 2,000 s. If necessary, surface regeneration was
    performed with 30 s injection of 50 mM NaOH (D44.1<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">des</sup>) or 10 mM NaOH (VEGF antibodies) at a
    flow rate of 30 μL/min. One flow cell contained no ligand and was used as a reference. The
    acquired data were analyzed using the device’s software, and kinetic fits were performed.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec022">IgG Western blot analysis
    (G6, G6<sup itemscope="" itemtype="http://schema.stenci.la/Superscript">des1</sup>, G6<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup>)</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">HEK293T cells were seeded on a
    24-well plate pre-coated with poly-L-lysine at 120,000 cells/well. The next day, cells were
    transfected with 1 μg DNA mixture consisting of 200 ng pLXN plasmid encoding Luciferase, 400 ng
    of a plasmid encoding the light chains and 400 ng of a plasmid encoding the heavy chains of the
    designated antibodies. Each transfection was carried in 100 μl DMEM in which 2 μg of linear
    40,000 Da PEI (Polysciences) per μg of DNA were mixed. The transfection mixture was added to
    cells, for a total volume of 400 μl DMEM per well. 4 hours after transfection, cells were washed
    and fresh 1 ml DMEM with 1% penicillin and streptomycin, glutamine and non-essential amino acids
    was applied. 72 hours post-transfection supernatant was separated from cells and the cells were
    resuspended in 500 μl PBS. A sample of 100 μl from the suspended cells from each well was
    transferred to 96-well white plates (Nunc) with 100 μl of Bright-Glo reagent (Promega) to
    quantify the level of luciferase as a proxy for the transfection efficiency. Adjusted volumes of
    supernatants based on the luciferase levels were loaded on a gradient gel (Bio-Rad) and run
    according to manufacturer&#39;s instructions. Semi-dry blotting was performed to a
    nitrocellulose membrane followed by blocking in 5% milk powder in TBST (0.1% Tween 20, 20 mM
    Tris pH 8.0, 150 mM sodium chloride) buffer for 30 min at room temperature. Donkey anti-human
    IgG conjugated to HRP (Abcam) was used to detect the human IgG scaffold for 1 h at room
    temperature.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec023">Mass spectrometry sample
    preparation</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Following IgG production in
    suspension (as described above), clarified media were aliquoted, snap frozen in liquid nitrogen
    and stored at -80°C. On the day of the measurements, samples were thawed and buffer exchanged
    into 1 M ammonium acetate, pH 7, using Micro Bio-Spin 6 Columns (Bio-Rad). To break all
    disulfide bonds, antibodies were then reduced for 4 h at 37°C in the presence of 20 mM TCEP,
    followed by two consecutive buffer exchanges into 1 M and 150 mM ammonium acetate, respectively.
  </p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec024">Native-mass spectrometry
  </h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Nanoelectrospray ionization
    (nano-ESI) MS experiments were performed on a modified Q-Exactive Plus Orbitrap EMR (Thermo
    Fisher Scientific, Bremen, Germany) [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref070">70</a></cite>]. All
    spectra are shown without smoothing. The instrument was calibrated externally, using cesium
    iodide. Typically, an aliquot of 2 μl protein solution was loaded into a gold-coated nano-ESI
    capillary prepared in-house, as previously described [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref071">71</a></cite>], and
    sprayed into the instrument. Conditions within the mass spectrometer were adjusted to preserve
    noncovalent interactions. The source was operated in positive mode, the capillary voltage was
    set to 1.7 kV, the capillary temperature was 180°C and argon was used as the collision gas in
    the higher-energy collision-induced dissociation (HCD) cell. MS spectra were recorded at a
    resolution of 10,000 and HCD voltage was set to 50 V, at trapping gas pressure setting of 3.9,
    which corresponds to HV pressure of 1.04 x 10<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">−4</sup> mbar and UHV pressure of 2.35 x 10<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">−10</sup> mbar. Bent flatapole DC
    bias and axial gradient were set to 2 V and 25 V, respectively.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec025">Gas-phase stability assay
  </h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Antibody stability was monitored by
    tandem MS (MS/MS), at different HCD voltages. The 23<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">+</sup> charge state of the G6 and G6<sup
      itemscope="" itemtype="http://schema.stenci.la/Superscript">des13</sup> antibodies was
    isolated in the quadrupole, with an isolation window of 20 m/z, and the transmitted ions were
    subjected to collision-induced dissociation in the HCD cell, at a gradient of accelerating
    voltages ranging between 50–200 V. The relative abundance of the full IgG’s and the dissociated
    light chains, recorded at the different HCD voltages, was determined by measuring their peak
    heights. The total intensity of the light chains was calculated as the sum of intensities of
    their corresponding charge states. In each experimental condition, the total intensities of all
    the measured species were summed and referenced as 100% intensity. The relative intensity of
    each species was then calculated as a percentage of the total intensity. The stability assay was
    performed six times. Error bars represent standard deviation.</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec026">Anti-QSOX1 antibody
    production</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The coding sequences for variable
    domains of antibody 492.1 were fused to human antibody constant regions [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref072">72</a></cite>].
    Mutations were introduced by site-directed mutagenesis into the resulting hybrid antibody
    expression plasmids according to published procedures [<cite itemscope=""
      itemtype="http://schema.stenci.la/Cite"><a href="#pcbi-1007207-ref073">73</a></cite>].
    Plasmids were transfected into suspension-adapted suspension-HEK 293F cells. The day before
    transfection, cells were split to 0.7 x 10<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">6</sup> cells/ml. For parallel expression of
    the parent hybrid antibody and the 20 variants, transfections were performed using 0.5 μg of
    each plasmid (heavy and light Ab chains) mixed with 3 μg PEI Max reagent (Polysciences Inc.) and
    incubated 20 min in 24-well tissue culture trays prior to addition of 1 ml cells per well.
    Plates were then agitated vigorously in a tissue culture incubator/shaker to prevent cell
    settling. After 4 days, cultures were transferred to microfuge tubes, and cells were pelleted by
    centrifugation at 500 x g for 10 min. Supernatants were transferred to fresh microfuge tubes,
    from which aliquots were taken for quantification of antibody expression and activity. For
    purification of selected Ab designs, transfections were done in 40 ml volumes, and plasmid and
    PEI Max amounts were scaled up accordingly. Cultures were grown for 6 days, and Ab was purified
    from the supernatant by protein G affinity chromatography (GE Healthcare).</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec027">QSOX1 dot blot and Western
    blot assays</h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Relative antibody concentrations were
    determined from culture supernatants by dot and Western blotting. Blotting was conducted in
    triplicate for each of two biological replicates. For dot blots, 2 μl of each supernatant was
    spotted onto nitrocellulose membranes. Membranes were then covered with a blocking solution of
    PBS containing 0.1% Tween (PBS-T) and 5% bovine serum albumin (BSA) and gently agitated for 1 h
    at room temperature. For western blots, 10 μl of each supernatant was applied with non-reducing
    gel loading buffer to 10% SDS polyacrylamide gels. After electrophoresis, proteins were
    transferred to nitrocellulose, and the membranes were incubated in PBS-T with 5% BSA under
    gentle agitation. For both dot and Western blots, horseradish peroxidase-conjugated antibody
    recognizing human Fc was added to the blocking solution after the first hour, and
    incubation/shaking was continued for another 45 min. The membrane was then washed three times
    for 5 min each with PBS-T, and the blot was developed using SuperSignal West Pico (ThermoFisher)
    chemiluminescent substrate. Dot and band intensities were recorded on a ChemiDoc XRS+ system
    (Bio-Rad).</p>
  <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec028">QSOX1 inhibition assays
  </h3>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">QSOX1 inhibition assays were
    conducted by using 5,5-dithio-bis-2-nitrobenzoic acid (DTNB) to quantify the remaining
    dithiothreitol (DTT) after incubation with purified recombinant QSOX1 and HEK293 culture
    supernatants or purified antibody. Culture supernatants (25 μl) were mixed in a clear,
    flat-bottom, 96-well plate with 12.5 μl of 40 nM QSOX1, and reactions were initiated by
    injection of 12.5 μl 600 μM DTT (final concentrations 10 nM QSOX1 and 150 μM DTT). Reactions
    were stopped after 30 min by adding 150 μl 500 μM DTNB, and absorbance at 412 nm was measured
    after 5 min in a Tecan microplate reader.</p>
  <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Purified antibody variants were
    quantified by absorbance at 280 nm after dilution into 6 M guanidine dissolved in PBS, using an
    extinction coefficient of 187,000 M<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">-1</sup>cm<sup itemscope=""
      itemtype="http://schema.stenci.la/Superscript">-1</sup>. Purified antibodies (12.5 μl) at
    concentrations of 40 nM, 100 nM, and 200 nM were mixed in a 96-well plate with 12.5 μl 100 nM
    QSOX1, and reactions were initiated by injection of 25 μl 600 μM DTT (final concentrations 25 nM
    QSOX1, 300 μM DTT, and 10, 25, or 50 nM antibody). Reactions were stopped after 20 min by adding
    150 μl 500 μM DTNB, and absorbance at 412 nm was measured after 5 min. Background-subtracted
    absorbance readings were normalized relative to the uninhibited and fully inhibited reactions
    (the latter mimicked by leaving QSOX1 out of the reaction), and results were plotted in <a
      href="#pcbi-1007207-g005" itemscope="" itemtype="http://schema.stenci.la/Link">Fig 5C</a> as
    the relative inhibitory activity.</p>
  <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec029">Supporting information
  </h2>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph"><strong itemscope=""
        itemtype="http://schema.stenci.la/Strong">a. Mutational tolerance mapping of the
        anti-lysozyme antibody D44.1.</strong> Mutations that were enriched, depleted, or had
      insufficient data in deep sequencing are marked in blue, red, and gray respectively. Wild type
      amino acids are indicated in one-letter codes for each position. Disulfide-bonded cysteines
      are marked in black triangles, and light-heavy chain interface positions in which point
      mutations exhibited over threefold enrichment relative to wild type, are marked in pink
      triangles. <strong itemscope="" itemtype="http://schema.stenci.la/Strong">b.</strong>
      Qualitative binding titrations using yeast display for D44.1, D44.1<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">des</sup>, and seven point mutants that
      comprise D44.1des using yeast surface display. Binding fluorescence intensities are relative
      to the highest concentration of 1 μM lysozyme.</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TIF)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph"><strong itemscope=""
        itemtype="http://schema.stenci.la/Strong">a.</strong> The crystal structure of D44.1<sup
        itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup> (yellow and green for
      heavy and light chains, respectively) shows high accuracy relative to the computational design
      (lavender). Electron density at 2 σ. <strong itemscope=""
        itemtype="http://schema.stenci.la/Strong">b.</strong> Crystallographic analysis of D44.1<sup
        itemscope="" itemtype="http://schema.stenci.la/Superscript">des</sup> shows high agreement
      with D44.1 (0.7 Å Cα root-mean-square deviation), including in the orientations of
      binding-surface residues (sticks; D44.1 in gray).</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TIF)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="computational-mutation-tolerance-mapping-enriches-for-low-energy-designs">Computational
      mutation tolerance mapping enriches for low-energy designs.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(blue) the distribution of Rosetta
      energies relative to G6 of a selection of &gt;150,000 unique multipoint mutants at 11
      positions encoded in the tolerated sequence space computed by PSSM (≥-1) and ΔΔ<em
        itemscope="" itemtype="http://schema.stenci.la/Emphasis">G</em> (≤+1 R.e.u.) filters.
      (green) a random set of multipoint mutants at 30 vL-vH interface (all interface positions were
      allowed), where any of the 19 amino acid mutations was allowed at each mutated position. In
      both sets, the same number of multipoint mutants was analyzed, and the same distribution of
      the number of mutations relative to G6 was implemented. 37% of the multipoint mutants had
      energies that were more favorable than G6, whereas less than 0.03% of the random mutants had
      more favorable energies than G6. Thus computational mutation tolerance mapping enriches for
      improved mutants by over 1,100-fold relative to random multipoint mutations.</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TIF)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="g6-g6des1-and-g6des13-fab-expression-and-purification">G6, G6<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">des1</sup>, and G6<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">des13</sup> Fab expression and purification.
    </h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(a) Following Ni-NTA purification,
      G6 exhibits the expected band at 50 kDa, and additional bands at approximately 100 kDa,
      indicative of sample heterogeneity. G6<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">des13</sup> and G6<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">des1</sup>, by contrast, primarily elute at
      the 50 kDa size range with no detectable higher-mass bands. (b) Designs G6<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">des13</sup> and G6<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">des1</sup> after gel filtration run at their
      expected sizes. The status of reducing conditions (without DTT and boiling) is indicated at
      the bottom of the gels.</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TIF)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="secreted-full-length-igg1-g6-and-g6des13-antibodies-were-reduced-and-analyzed-by-native-mass-spec-directly-from-the-growth-medium">
      Secreted full-length IgG1 G6 and G6<sup itemscope=""
        itemtype="http://schema.stenci.la/Superscript">des13</sup> antibodies were reduced and
      analyzed by native mass-spec directly from the growth medium.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Upper panels show the full spectra.
      Charge state series of the two antibodies are labeled by dark blue and light blue circles,
      respectively. The +23 charge state of each antibody was isolated in the quadrupole and
      subjected to a gradual elevation of collision voltage in a stepwise manner, ranging from 50 to
      200 V. Light chains, which gradually dissociated from the intact antibodies, are labeled the
      by red and orange circles.</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TIF)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="all-20-h4921-designs-were-expressed-and-their-activities-from-culture-supernatants-were-measured-as-described-in-the-methods">
      All 20 h492.1 designs were expressed, and their activities from culture supernatants were
      measured as described in the methods.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The highest values in the blot
      reflect the greatest amounts of substrate remaining at the end of a QSOX1 sulfhydryl oxidase
      activity assay, indicating the greatest inhibition of QSOX1 by the antibody. Due to
      differences in expression levels (<a href="#pcbi-1007207-g005" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 5A and 5B</a>), inhibitory activity in this
      experiment reflects a combination of expression yield and intrinsic activity. The designs with
      results plotted in color (yellow and pink) were expressed in larger volumes, purified, and
      compared quantitatively for inhibitory activity compared to the parental 492.1 antibody
      purified from a hybridoma (<a href="#pcbi-1007207-g005" itemscope=""
        itemtype="http://schema.stenci.la/Link">Fig 5C</a>).</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TIF)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="data-collection-and-refinement-statistics-for-d441des-pdb-code-6gc2">Data collection and
      refinement statistics for D44.1des, PDB code 6GC2.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(XLSX)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="the-mutated-positions-and-identities-in-g6-designs-colored-according-to-their-physicochemical-properties-and-sorted-by-normalized-fluorescence-value-measured-by-yeast-display-experiments">
      The mutated positions and identities in G6 designs, colored according to their physicochemical
      properties and sorted by normalized fluorescence value (measured by yeast display
      experiments).</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(DOCX)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="the-mutated-positions-and-identities-in-anti-qsox1-4921-designs-colored-according-to-their-physicochemical-properties">
      The mutated positions and identities in anti-QSOX1 492.1 designs, colored according to their
      physicochemical properties.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(DOCX)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="log-enrichment-of-the-deep-mutational-scanning-data-of-anti-lysozyme-antibody-d44">
      Log-enrichment of the deep mutational scanning data of anti-lysozyme antibody D44.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Data retrieved from the deep
      mutational scanning analysis of enrichment over WT for single point substitutions.</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(XLSX)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="rosettascript-for-refinement-of-structures-retrieved-from-the-pdb">RosettaScript for
      refinement of structures retrieved from the PDB.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TXT)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="rosettascript-for-single-point-mutational-scanning">RosettaScript for single-point
      mutational scanning.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TXT)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="rosettascript-for-combinatorial-sequence-design">RosettaScript for combinatorial sequence
      design.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">An example of a protocol for
      designing a specific combinatorial mutant.</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TXT)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="dna-sequences-of-tested-constructs">DNA sequences of tested constructs.</h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(DOCX)</p>
  </div>
  <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
      itemtype="http://schema.org/Organization" itemprop="publisher">
      <meta itemprop="name" content="Unknown"><span itemscope=""
        itemtype="http://schema.org/ImageObject" itemprop="logo">
        <meta itemprop="url"
          content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown"></span></span>
    <ol data-itemprop="authors"></ol>
    <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
      id="amino-acid-sequences-of-g6-and-g6des13-iggs">Amino acid sequences of G6 and G6des13 IgGs.
    </h3>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Protein sequences used in the mass
      spectrometry analyses.</p>
    <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(DOCX)</p>
  </div>
  <section data-itemprop="references">
    <h2 data-itemtype="http://schema.stenci.la/Heading">References</h2>
    <ol>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref001">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JP Acierno"><span data-itemprop="givenNames"><span
                itemprop="givenName">JP</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Acierno</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="BC Braden"><span data-itemprop="givenNames"><span
                itemprop="givenName">BC</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Braden</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Klinke"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Klinke</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="FA Goldbaum"><span data-itemprop="givenNames"><span
                itemprop="givenName">FA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Goldbaum</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Cauerhff"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Cauerhff</span></span></li>
        </ol><time itemprop="datePublished" datetime="2007">2007</time><span
          itemprop="headline">Affinity Maturation Increases the Stability and Plasticity of the Fv
          Domain of Anti-protein Antibodies</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">374</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">J Mol Biol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">130</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">146</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Affinity%20Maturation%20Increases%20the%20Stability%20and%20Plasticity%20of%20the%20Fv%20Domain%20of%20Anti-protein%20Antibodies">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref002">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="V Saxena"><span data-itemprop="givenNames"><span
                itemprop="givenName">V</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Saxena</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Panicucci"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Panicucci</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Joshi"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Joshi</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Garad"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Garad</span></span></li>
        </ol><time itemprop="datePublished" datetime="2009">2009</time><span itemprop="headline"
          content="Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable …">Developability
          assessment in pharmaceutical industry: An integrated group approach for selecting
          developable candidates</span><span itemscope="" itemtype="http://schema.org/Periodical"
          itemprop="isPartOf"><span itemprop="name">Journal of Pharmaceutical
            Sciences</span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1962</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1979</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Developability%20assessment%20in%20pharmaceutical%20industry:%20An%20integrated%20group%20approach%20for%20selecting%20developable%20%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref003">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Chao"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Chao</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="WL Lau"><span data-itemprop="givenNames"><span
                itemprop="givenName">WL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lau</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="BJ Hackel"><span data-itemprop="givenNames"><span
                itemprop="givenName">BJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Hackel</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SL Sazinsky"><span data-itemprop="givenNames"><span
                itemprop="givenName">SL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Sazinsky</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SM Lippow"><span data-itemprop="givenNames"><span
                itemprop="givenName">SM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lippow</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="KD Wittrup"><span data-itemprop="givenNames"><span
                itemprop="givenName">KD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wittrup</span></span></li>
        </ol><time itemprop="datePublished" datetime="2006">2006</time><span
          itemprop="headline">Isolating and engineering human antibodies using yeast surface
          display</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">1</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Nat
              Protoc</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">755</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">768</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Isolating%20and%20engineering%20human%20antibodies%20using%20yeast%20surface%20display">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref004">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="ET Boder"><span data-itemprop="givenNames"><span
                itemprop="givenName">ET</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Boder</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="KS Midelfort"><span data-itemprop="givenNames"><span
                itemprop="givenName">KS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Midelfort</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="KD Wittrup"><span data-itemprop="givenNames"><span
                itemprop="givenName">KD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wittrup</span></span></li>
        </ol><time itemprop="datePublished" datetime="2000">2000</time><span
          itemprop="headline">Directed evolution of antibody fragments with monovalent femtomolar
          antigen-binding affinity</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">97</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proc Natl Acad Sci U S A</span></span></span><span
          itemprop="pageStart" data-itemtype="http://schema.org/Number">10701</span><span
          itemprop="pageEnd" data-itemtype="http://schema.org/Number">10705</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Directed%20evolution%20of%20antibody%20fragments%20with%20monovalent%20femtomolar%20antigen-binding%20affinity">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref005">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="KS Midelfort"><span data-itemprop="givenNames"><span
                itemprop="givenName">KS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Midelfort</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="HH Hernandez"><span data-itemprop="givenNames"><span
                itemprop="givenName">HH</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Hernandez</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SM Lippow"><span data-itemprop="givenNames"><span
                itemprop="givenName">SM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lippow</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="B Tidor"><span data-itemprop="givenNames"><span
                itemprop="givenName">B</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tidor</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="CL Drennan"><span data-itemprop="givenNames"><span
                itemprop="givenName">CL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Drennan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="KD Wittrup"><span data-itemprop="givenNames"><span
                itemprop="givenName">KD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wittrup</span></span></li>
        </ol><time itemprop="datePublished" datetime="2004">2004</time><span
          itemprop="headline">Substantial energetic improvement with minimal structural perturbation
          in a high affinity mutant antibody</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">343</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">J Mol Biol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">685</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">701</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Substantial%20energetic%20improvement%20with%20minimal%20structural%20perturbation%20in%20a%20high%20affinity%20mutant%20antibody">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref006">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MC Julian"><span data-itemprop="givenNames"><span
                itemprop="givenName">MC</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Julian</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="L Li"><span data-itemprop="givenNames"><span
                itemprop="givenName">L</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Li</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Garde"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Garde</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Wilen"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wilen</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="PM Tessier"><span data-itemprop="givenNames"><span
                itemprop="givenName">PM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tessier</span></span></li>
        </ol><time itemprop="datePublished" datetime="2017">2017</time><span itemprop="headline"
          content="Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to…">Efficient
          affinity maturation of antibody variable domains requires co-selection of compensatory
          mutations to maintain thermodynamic stability</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">7</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Sci Rep</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">45259</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Efficient%20affinity%20maturation%20of%20antibody%20variable%20domains%20requires%20co-selection%20of%20compensatory%20mutations%20to%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref007">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Ponsel"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ponsel</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Neugebauer"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Neugebauer</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="K Ladetzki-Baehs"><span data-itemprop="givenNames"><span
                itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ladetzki-Baehs</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="K Tissot"><span data-itemprop="givenNames"><span
                itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tissot</span></span></li>
        </ol><time itemprop="datePublished" datetime="2011">2011</time><span
          itemprop="headline">High affinity, developability and functional size: The holy grail of
          combinatorial antibody library generation</span><span itemscope=""
          itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
            itemprop="name">Molecules</span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">3675</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">3700</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=High%20affinity,%20developability%20and%20functional%20size:%20The%20holy%20grail%20of%20combinatorial%20antibody%20library%20generation">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref008">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MEM Cromwell"><span data-itemprop="givenNames"><span
                itemprop="givenName">MEM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Cromwell</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="E Hilario"><span data-itemprop="givenNames"><span
                itemprop="givenName">E</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Hilario</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="F Jacobson"><span data-itemprop="givenNames"><span
                itemprop="givenName">F</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Jacobson</span></span></li>
        </ol><time itemprop="datePublished" datetime="2006">2006</time><span
          itemprop="headline">Protein aggregation and bioprocessing</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">8</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">AAPS J</span></span></span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">9</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Protein%20aggregation%20and%20bioprocessing">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref009">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="AS Rosenberg"><span data-itemprop="givenNames"><span
                itemprop="givenName">AS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Rosenberg</span></span></li>
        </ol><time itemprop="datePublished" datetime="2006">2006</time><span
          itemprop="headline">Effects of protein aggregates: an immunologic perspective</span><span
          itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">8</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">AAPS J</span></span></span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">7</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Effects%20of%20protein%20aggregates:%20an%20immunologic%20perspective">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref010">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="X Yang"><span data-itemprop="givenNames"><span
                itemprop="givenName">X</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Yang</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="W Xu"><span data-itemprop="givenNames"><span
                itemprop="givenName">W</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Xu</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Dukleska"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dukleska</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Benchaar"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Benchaar</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Mengisen"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Mengisen</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="V Antochshuk"><span data-itemprop="givenNames"><span
                itemprop="givenName">V</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Antochshuk</span></span></li>
        </ol><time itemprop="datePublished" datetime="2013">2013</time><span itemprop="headline"
          content="Developability studies before initiation of process development: improving manufacturability of monoclonal an…">Developability
          studies before initiation of process development: improving manufacturability of
          monoclonal antibodies</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">5</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">MAbs</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">787</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">794</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Developability%20studies%20before%20initiation%20of%20process%20development:%20improving%20manufacturability%20of%20monoclonal%20an%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref011">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Beck"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Beck</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Wurch"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wurch</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="C Bailly"><span data-itemprop="givenNames"><span
                itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Bailly</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="N Corvaia"><span data-itemprop="givenNames"><span
                itemprop="givenName">N</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Corvaia</span></span></li>
        </ol><time itemprop="datePublished" datetime="2010">2010</time><span
          itemprop="headline">Strategies and challenges for the next generation of therapeutic
          antibodies</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">10</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Nat
              Rev Immunol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">345</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">352</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Strategies%20and%20challenges%20for%20the%20next%20generation%20of%20therapeutic%20antibodies">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref012">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SM Lippow"><span data-itemprop="givenNames"><span
                itemprop="givenName">SM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lippow</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="KD Wittrup"><span data-itemprop="givenNames"><span
                itemprop="givenName">KD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wittrup</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="B Tidor"><span data-itemprop="givenNames"><span
                itemprop="givenName">B</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tidor</span></span></li>
        </ol><time itemprop="datePublished" datetime="2007">2007</time><span
          itemprop="headline">Computational design of antibody-affinity improvement beyond in vivo
          maturation</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">25</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Nat
              Biotechnol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1171</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1176</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Computational%20design%20of%20antibody-affinity%20improvement%20beyond%20in%20vivo%20maturation">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref013">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="N Chennamsetty"><span data-itemprop="givenNames"><span
                itemprop="givenName">N</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Chennamsetty</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="V Voynov"><span data-itemprop="givenNames"><span
                itemprop="givenName">V</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Voynov</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="V Kayser"><span data-itemprop="givenNames"><span
                itemprop="givenName">V</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kayser</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="B Helk"><span data-itemprop="givenNames"><span
                itemprop="givenName">B</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Helk</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="BL Trout"><span data-itemprop="givenNames"><span
                itemprop="givenName">BL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Trout</span></span></li>
        </ol><time itemprop="datePublished" datetime="2009">2009</time><span
          itemprop="headline">Design of therapeutic proteins with enhanced stability</span><span
          itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">106</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proc Natl Acad Sci U S A</span></span></span><span
          itemprop="pageStart" data-itemtype="http://schema.org/Number">11937</span><span
          itemprop="pageEnd" data-itemtype="http://schema.org/Number">11942</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Design%20of%20therapeutic%20proteins%20with%20enhanced%20stability">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref014">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Jain"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Jain</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Sun"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Sun</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Durand"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Durand</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Hall"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Hall</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="NR Houston"><span data-itemprop="givenNames"><span
                itemprop="givenName">NR</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Houston</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JH Nett"><span data-itemprop="givenNames"><span
                itemprop="givenName">JH</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Nett</span></span></li>
        </ol><time itemprop="datePublished" datetime="2017">2017</time><span
          itemprop="headline">Biophysical properties of the clinical-stage antibody
          landscape</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">114</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Proc
              Natl Acad Sci U S A</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">944</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">949</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Biophysical%20properties%20of%20the%20clinical-stage%20antibody%20landscape">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref015">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Seeliger"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Seeliger</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Schulz"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Schulz</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Litzenburger"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Litzenburger</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Spitz"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Spitz</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Hoerer"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Hoerer</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Blech"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Blech</span></span></li>
        </ol><time itemprop="datePublished" datetime="2015">2015</time><span
          itemprop="headline">Boosting antibody developability through rational sequence
          optimization</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">7</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">MAbs</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">505</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">515</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Boosting%20antibody%20developability%20through%20rational%20sequence%20optimization">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref016">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="K Dudgeon"><span data-itemprop="givenNames"><span
                itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dudgeon</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Rouet"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Rouet</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="I Kokmeijer"><span data-itemprop="givenNames"><span
                itemprop="givenName">I</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kokmeijer</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Schofield"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Schofield</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Stolp"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Stolp</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Langley"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Langley</span></span></li>
        </ol><time itemprop="datePublished" datetime="2012">2012</time><span
          itemprop="headline">General strategy for the generation of human antibody variable domains
          with increased aggregation resistance</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">109</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proc Natl Acad Sci U S A</span></span></span><span
          itemprop="pageStart" data-itemtype="http://schema.org/Number">10879</span><span
          itemprop="pageEnd" data-itemtype="http://schema.org/Number">10884</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=General%20strategy%20for%20the%20generation%20of%20human%20antibody%20variable%20domains%20with%20increased%20aggregation%20resistance">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref017">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="AE Miklos"><span data-itemprop="givenNames"><span
                itemprop="givenName">AE</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Miklos</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="C Kluwe"><span data-itemprop="givenNames"><span
                itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kluwe</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="BS Der"><span data-itemprop="givenNames"><span
                itemprop="givenName">BS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Der</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Pai"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Pai</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Sircar"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Sircar</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R a. Hughes"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span><span itemprop="givenName">a.</span></span><span
              data-itemprop="familyNames"><span itemprop="familyName">Hughes</span></span></li>
        </ol><time itemprop="datePublished" datetime="2012">2012</time><span
          itemprop="headline">Structure-based design of supercharged, highly thermoresistant
          antibodies</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">19</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Chem
              Biol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">449</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">455</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Structure-based%20design%20of%20supercharged,%20highly%20thermoresistant%20antibodies">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref018">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="L Jespers"><span data-itemprop="givenNames"><span
                itemprop="givenName">L</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Jespers</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Schon"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Schon</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="K Famm"><span data-itemprop="givenNames"><span
                itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Famm</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Winter"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Winter</span></span></li>
        </ol><time itemprop="datePublished" datetime="2004">2004</time><span
          itemprop="headline">Aggregation-resistant domain antibodies selected on phage by heat
          denaturation</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">22</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Nat
              Biotechnol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1161</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1165</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Aggregation-resistant%20domain%20antibodies%20selected%20on%20phage%20by%20heat%20denaturation">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref019">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Cauerhff"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Cauerhff</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="FA Goldbaum"><span data-itemprop="givenNames"><span
                itemprop="givenName">FA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Goldbaum</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="BC Braden"><span data-itemprop="givenNames"><span
                itemprop="givenName">BC</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Braden</span></span></li>
        </ol><time itemprop="datePublished" datetime="2004">2004</time><span
          itemprop="headline">Structural mechanism for affinity maturation of an anti-lysozyme
          antibody</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">101</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Proc
              Natl Acad Sci U S A</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">3539</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">3544</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Structural%20mechanism%20for%20affinity%20maturation%20of%20an%20anti-lysozyme%20antibody">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref020">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Goldenzweig"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Goldenzweig</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Goldsmith"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Goldsmith</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SE Hill"><span data-itemprop="givenNames"><span
                itemprop="givenName">SE</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Hill</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Gertman"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Gertman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Laurino"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Laurino</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Ashani"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ashani</span></span></li>
        </ol><time itemprop="datePublished" datetime="2016">2016</time><span
          itemprop="headline">Automated Structure-and Sequence-Based Design of Proteins for High
          Bacterial Expression and Stability</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">63</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Mol Cell</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">337</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">346</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Automated%20Structure-and%20Sequence-Based%20Design%20of%20Proteins%20for%20High%20Bacterial%20Expression%20and%20Stability">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref021">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Goldenzweig"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Goldenzweig</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
        </ol><time itemprop="datePublished" datetime="2018">2018</time><span
          itemprop="headline">Principles of Protein Stability and Their Application in Computational
          Design</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">87</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Annu
              Rev Biochem</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">105</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">129</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Principles%20of%20Protein%20Stability%20and%20Their%20Application%20in%20Computational%20Design">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref022">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="I Campeotto"><span data-itemprop="givenNames"><span
                itemprop="givenName">I</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Campeotto</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Goldenzweig"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Goldenzweig</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Davey"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Davey</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="L Barfod"><span data-itemprop="givenNames"><span
                itemprop="givenName">L</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Barfod</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JM Marshall"><span data-itemprop="givenNames"><span
                itemprop="givenName">JM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Marshall</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SE Silk"><span data-itemprop="givenNames"><span
                itemprop="givenName">SE</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Silk</span></span></li>
        </ol><time itemprop="datePublished" datetime="2017">2017</time><span
          itemprop="headline">One-step design of a stable variant of the malaria invasion protein
          RH5 for use as a vaccine immunogen</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">114</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proc Natl Acad Sci U S A</span></span></span><span
          itemprop="pageStart" data-itemtype="http://schema.org/Number">998</span><span
          itemprop="pageEnd" data-itemtype="http://schema.org/Number">1002</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=One-step%20design%20of%20a%20stable%20variant%20of%20the%20malaria%20invasion%20protein%20RH5%20for%20use%20as%20a%20vaccine%20immunogen">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref023">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="B Borgo"><span data-itemprop="givenNames"><span
                itemprop="givenName">B</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Borgo</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JJ Havranek"><span data-itemprop="givenNames"><span
                itemprop="givenName">JJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Havranek</span></span></li>
        </ol><time itemprop="datePublished" datetime="2012">2012</time><span
          itemprop="headline">Automated selection of stabilizing mutations in designed and natural
          proteins</span><span itemscope="" itemtype="http://schema.org/Periodical"
          itemprop="isPartOf"><span itemprop="name">Proceedings of the National Academy of
            Sciences</span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1494</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1499</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Automated%20selection%20of%20stabilizing%20mutations%20in%20designed%20and%20natural%20proteins">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref024">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="TA Whitehead"><span data-itemprop="givenNames"><span
                itemprop="givenName">TA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Whitehead</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Chevalier"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Chevalier</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Song"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Song</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="C Dreyfus"><span data-itemprop="givenNames"><span
                itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dreyfus</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="C De Mattos"><span data-itemprop="givenNames"><span
                itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">De</span><span itemprop="familyName">Mattos</span></span></li>
        </ol><time itemprop="datePublished" datetime="2012">2012</time><span
          itemprop="headline">Optimization of affinity, specificity and function of designed
          influenza inhibitors using deep sequencing</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">30</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Nat Biotechnol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">543</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">548</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Optimization%20of%20affinity,%20specificity%20and%20function%20of%20designed%20influenza%20inhibitors%20using%20deep%20sequencing">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref025">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="DM Fowler"><span data-itemprop="givenNames"><span
                itemprop="givenName">DM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fowler</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Fields"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fields</span></span></li>
        </ol><time itemprop="datePublished" datetime="2014">2014</time><span
          itemprop="headline">Deep mutational scanning: a new style of protein science</span><span
          itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">11</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Nat Methods</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">801</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">807</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Deep%20mutational%20scanning:%20a%20new%20style%20of%20protein%20science">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref026">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="DM Fowler"><span data-itemprop="givenNames"><span
                itemprop="givenName">DM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fowler</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="CL Araya"><span data-itemprop="givenNames"><span
                itemprop="givenName">CL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Araya</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="EH Kellogg"><span data-itemprop="givenNames"><span
                itemprop="givenName">EH</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kellogg</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JJ Stephany"><span data-itemprop="givenNames"><span
                itemprop="givenName">JJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Stephany</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Baker"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Baker</span></span></li>
        </ol><time itemprop="datePublished" datetime="2010">2010</time><span
          itemprop="headline">High-resolution mapping of protein sequence-function
          relationships</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">7</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Nat
              Methods</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">741</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">746</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=High-resolution%20mapping%20of%20protein%20sequence-function%20relationships">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref027">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Koenig"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Koenig</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="CV Lee"><span data-itemprop="givenNames"><span
                itemprop="givenName">CV</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lee</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="BT Walters"><span data-itemprop="givenNames"><span
                itemprop="givenName">BT</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Walters</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="V Janakiraman"><span data-itemprop="givenNames"><span
                itemprop="givenName">V</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Janakiraman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Stinson"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Stinson</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="TW Patapoff"><span data-itemprop="givenNames"><span
                itemprop="givenName">TW</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Patapoff</span></span></li>
        </ol><time itemprop="datePublished" datetime="2017">2017</time><span itemprop="headline"
          content="Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational …">Mutational
          landscape of antibody variable domains reveals a switch modulating the interdomain
          conformational dynamics and antigen binding</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">114</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proc Natl Acad Sci U S A</span></span></span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Mutational%20landscape%20of%20antibody%20variable%20domains%20reveals%20a%20switch%20modulating%20the%20interdomain%20conformational%20%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref028">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="CM Forsyth"><span data-itemprop="givenNames"><span
                itemprop="givenName">CM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Forsyth</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="V Juan"><span data-itemprop="givenNames"><span
                itemprop="givenName">V</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Juan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Akamatsu"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Akamatsu</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="RB DuBridge"><span data-itemprop="givenNames"><span
                itemprop="givenName">RB</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">DuBridge</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Doan"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Doan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="AV Ivanov"><span data-itemprop="givenNames"><span
                itemprop="givenName">AV</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ivanov</span></span></li>
        </ol><time itemprop="datePublished" datetime="2013">2013</time><span itemprop="headline"
          content="Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display…">Deep
          mutational scanning of an antibody against epidermal growth factor receptor using
          mammalian cell display and massively parallel pyrosequencing</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">5</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">MAbs</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">523</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">532</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Deep%20mutational%20scanning%20of%20an%20antibody%20against%20epidermal%20growth%20factor%20receptor%20using%20mammalian%20cell%20display%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref029">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Fujino"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fujino</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Fujita"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fujita</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="K Wada"><span data-itemprop="givenNames"><span
                itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wada</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="K Fujishige"><span data-itemprop="givenNames"><span
                itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fujishige</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Kanamori"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kanamori</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="L Hunt"><span data-itemprop="givenNames"><span
                itemprop="givenName">L</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Hunt</span></span></li>
        </ol><time itemprop="datePublished" datetime="2012">2012</time><span
          itemprop="headline">Robust in vitro affinity maturation strategy based on
          interface-focused high-throughput mutational scanning</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">428</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Biochem Biophys Res Commun</span></span></span><span
          itemprop="pageStart" data-itemtype="http://schema.org/Number">395</span><span
          itemprop="pageEnd" data-itemtype="http://schema.org/Number">400</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Robust%20in%20vitro%20affinity%20maturation%20strategy%20based%20on%20interface-focused%20high-throughput%20mutational%20scanning">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref030">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="RM Adams"><span data-itemprop="givenNames"><span
                itemprop="givenName">RM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Adams</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Mora"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Mora</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="AM Walczak"><span data-itemprop="givenNames"><span
                itemprop="givenName">AM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Walczak</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JB Kinney"><span data-itemprop="givenNames"><span
                itemprop="givenName">JB</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kinney</span></span></li>
        </ol><time itemprop="datePublished" datetime="2016">2016</time><span
          itemprop="headline">Measuring the sequence-affinity landscape of antibodies with massively
          parallel titration curves</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">5</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Elife</span></span></span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Measuring%20the%20sequence-affinity%20landscape%20of%20antibodies%20with%20massively%20parallel%20titration%20curves">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref031">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="I Leung"><span data-itemprop="givenNames"><span
                itemprop="givenName">I</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Leung</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Dekel"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dekel</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JM Shifman"><span data-itemprop="givenNames"><span
                itemprop="givenName">JM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Shifman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SS Sidhu"><span data-itemprop="givenNames"><span
                itemprop="givenName">SS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Sidhu</span></span></li>
        </ol><time itemprop="datePublished" datetime="2016">2016</time><span
          itemprop="headline">Saturation scanning of ubiquitin variants reveals a common hot spot
          for binding to USP2 and USP21</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">113</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proc Natl Acad Sci U S A</span></span></span><span
          itemprop="pageStart" data-itemtype="http://schema.org/Number">8705</span><span
          itemprop="pageEnd" data-itemtype="http://schema.org/Number">8710</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Saturation%20scanning%20of%20ubiquitin%20variants%20reveals%20a%20common%20hot%20spot%20for%20binding%20to%20USP2%20and%20USP21">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref032">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="TA Whitehead"><span data-itemprop="givenNames"><span
                itemprop="givenName">TA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Whitehead</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Baker"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Baker</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
        </ol><time itemprop="datePublished" datetime="2013">2013</time><span
          itemprop="headline">Computational design of novel protein binders and experimental
          affinity maturation</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">523</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Methods Enzymol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">19</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Computational%20design%20of%20novel%20protein%20binders%20and%20experimental%20affinity%20maturation">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref033">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="BC Braden"><span data-itemprop="givenNames"><span
                itemprop="givenName">BC</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Braden</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Souchon"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Souchon</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JL Eiselé"><span data-itemprop="givenNames"><span
                itemprop="givenName">JL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Eiselé</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="GA Bentley"><span data-itemprop="givenNames"><span
                itemprop="givenName">GA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Bentley</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="TN Bhat"><span data-itemprop="givenNames"><span
                itemprop="givenName">TN</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Bhat</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Navaza"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Navaza</span></span></li>
        </ol><time itemprop="datePublished" datetime="1994">1994</time><span itemprop="headline"
          content="Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody…">Three-dimensional
          structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme
          antibody D44.1</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">243</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">J Mol
              Biol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">767</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">781</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Three-dimensional%20structures%20of%20the%20free%20and%20the%20antigen-complexed%20Fab%20from%20monoclonal%20anti-lysozyme%20antibody%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref034">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="PM Colman"><span data-itemprop="givenNames"><span
                itemprop="givenName">PM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Colman</span></span></li>
        </ol><time itemprop="datePublished" datetime="1988">1988</time><span
          itemprop="headline">Structure of antibody-antigen complexes: implications for immune
          recognition</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">43</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Adv
              Immunol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">99</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">132</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Structure%20of%20antibody-antigen%20complexes:%20implications%20for%20immune%20recognition">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref035">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Zimmermann"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Zimmermann</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="EL Oakman"><span data-itemprop="givenNames"><span
                itemprop="givenName">EL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Oakman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="IF Thorpe"><span data-itemprop="givenNames"><span
                itemprop="givenName">IF</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Thorpe</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="X Shi"><span data-itemprop="givenNames"><span
                itemprop="givenName">X</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Shi</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Abbyad"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Abbyad</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="CL Brooks"><span data-itemprop="givenNames"><span
                itemprop="givenName">CL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Brooks</span></span></li>
        </ol><time itemprop="datePublished" datetime="2006">2006</time><span
          itemprop="headline">Antibody evolution constrains conformational heterogeneity by
          tailoring protein dynamics</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">103</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proceedings of the National Academy of
              Sciences</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">13722</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">13727</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Antibody%20evolution%20constrains%20conformational%20heterogeneity%20by%20tailoring%20protein%20dynamics">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref036">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="LA Clark"><span data-itemprop="givenNames"><span
                itemprop="givenName">LA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Clark</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Ganesan"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ganesan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Papp"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Papp</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="HWT van Vlijmen"><span data-itemprop="givenNames"><span
                itemprop="givenName">HWT</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">van</span><span itemprop="familyName">Vlijmen</span></span>
          </li>
        </ol><time itemprop="datePublished" datetime="2006">2006</time><span
          itemprop="headline">Trends in antibody sequence changes during the somatic hypermutation
          process</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">177</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">J
              Immunol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">333</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">340</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Trends%20in%20antibody%20sequence%20changes%20during%20the%20somatic%20hypermutation%20process">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref037">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JR Adair"><span data-itemprop="givenNames"><span
                itemprop="givenName">JR</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Adair</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="DS Athwal"><span data-itemprop="givenNames"><span
                itemprop="givenName">DS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Athwal</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JS Emtage"><span data-itemprop="givenNames"><span
                itemprop="givenName">JS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Emtage</span></span></li>
        </ol><time itemprop="datePublished" datetime="1995">1995</time><span
          itemprop="headline">Humanised antibodies</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">460167</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">European Patent</span></span></span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Humanised%20antibodies">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref038">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="GD Lapidoth"><span data-itemprop="givenNames"><span
                itemprop="givenName">GD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lapidoth</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Baran"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Baran</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="GM Pszolla"><span data-itemprop="givenNames"><span
                itemprop="givenName">GM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Pszolla</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="C Norn"><span data-itemprop="givenNames"><span
                itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Norn</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Alon"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Alon</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MD Tyka"><span data-itemprop="givenNames"><span
                itemprop="givenName">MD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tyka</span></span></li>
        </ol><time itemprop="datePublished" datetime="2015">2015</time><span
          itemprop="headline">AbDesign: An algorithm for combinatorial backbone design guided by
          natural conformations and sequences</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">83</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proteins</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1385</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1406</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=AbDesign:%20An%20algorithm%20for%20combinatorial%20backbone%20design%20guided%20by%20natural%20conformations%20and%20sequences">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref039">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Baran"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Baran</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MG Pszolla"><span data-itemprop="givenNames"><span
                itemprop="givenName">MG</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Pszolla</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="GD Lapidoth"><span data-itemprop="givenNames"><span
                itemprop="givenName">GD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lapidoth</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="C Norn"><span data-itemprop="givenNames"><span
                itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Norn</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Dym"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dym</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Unger"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Unger</span></span></li>
        </ol><time itemprop="datePublished" datetime="2017">2017</time><span
          itemprop="headline">Principles for computational design of binding antibodies</span><span
          itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">114</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proc Natl Acad Sci U S A</span></span></span><span
          itemprop="pageStart" data-itemtype="http://schema.org/Number">10900</span><span
          itemprop="pageEnd" data-itemtype="http://schema.org/Number">10905</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Principles%20for%20computational%20design%20of%20binding%20antibodies">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref040">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Lapidoth"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lapidoth</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Khersonsky"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Khersonsky</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Lipsh"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lipsh</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Dym"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dym</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Albeck"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Albeck</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Rogotner"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Rogotner</span></span></li>
        </ol><time itemprop="datePublished" datetime="2018">2018</time><span
          itemprop="headline">Highly active enzymes by automated combinatorial backbone assembly and
          sequence design</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">9</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Nat
              Commun</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">2780</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Highly%20active%20enzymes%20by%20automated%20combinatorial%20backbone%20assembly%20and%20sequence%20design">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref041">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Khersonsky"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Khersonsky</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Lipsh"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lipsh</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Z Avizemer"><span data-itemprop="givenNames"><span
                itemprop="givenName">Z</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Avizemer</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Ashani"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ashani</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Goldsmith"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Goldsmith</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Leader"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Leader</span></span></li>
        </ol><time itemprop="datePublished" datetime="2018">2018</time><span
          itemprop="headline">Automated Design of Efficient and Functionally Diverse Enzyme
          Repertoires</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">72</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">Mol
              Cell</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">178</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">186</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Automated%20Design%20of%20Efficient%20and%20Functionally%20Diverse%20Enzyme%20Repertoires">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref042">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Netzer"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Netzer</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Listov"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Listov</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Lipsh"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lipsh</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Dym"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dym</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Albeck"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Albeck</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Knop"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Knop</span></span></li>
        </ol><time itemprop="datePublished" datetime="2018">2018</time><span
          itemprop="headline">Ultrahigh specificity in a network of computationally designed
          protein-interaction pairs</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">9</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Nat Commun</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">5286</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Ultrahigh%20specificity%20in%20a%20network%20of%20computationally%20designed%20protein-interaction%20pairs">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref043">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Khersonsky"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Khersonsky</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
        </ol><time itemprop="datePublished" datetime="2016">2016</time><span itemprop="headline">Why
          reinvent the wheel? Building new proteins based on ready-made parts</span><span
          itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">25</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Protein Sci</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1179</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1187</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Why%20reinvent%20the%20wheel?%20Building%20new%20proteins%20based%20on%20ready-made%20parts">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref044">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="KR Abhinandan"><span data-itemprop="givenNames"><span
                itemprop="givenName">KR</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Abhinandan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="ACR Martin"><span data-itemprop="givenNames"><span
                itemprop="givenName">ACR</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Martin</span></span></li>
        </ol><time itemprop="datePublished" datetime="2010">2010</time><span
          itemprop="headline">Analysis and prediction of VH/VL packing in antibodies</span><span
          itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">23</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Protein Eng Des Sel</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">689</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">697</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Analysis%20and%20prediction%20of%20VH/VL%20packing%20in%20antibodies">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref045">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Fuh"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fuh</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Wu"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wu</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="W-C Liang"><span data-itemprop="givenNames"><span
                itemprop="givenName">W-C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Liang</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Ultsch"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ultsch</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="CV Lee"><span data-itemprop="givenNames"><span
                itemprop="givenName">CV</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lee</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="B Moffat"><span data-itemprop="givenNames"><span
                itemprop="givenName">B</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Moffat</span></span></li>
        </ol><time itemprop="datePublished" datetime="2006">2006</time><span itemprop="headline"
          content="Structure-Function Studies of Two Synthetic Anti-vascular Endothelial Growth Factor Fabs and Comparison with …">Structure-Function
          Studies of Two Synthetic Anti-vascular Endothelial Growth Factor Fabs and Comparison with
          the Avastin Fab</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">281</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">J Biol
              Chem</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">6625</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">6631</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Structure-Function%20Studies%20of%20Two%20Synthetic%20Anti-vascular%20Endothelial%20Growth%20Factor%20Fabs%20and%20Comparison%20with%20%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref046">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Song"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Song</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="B Zhang"><span data-itemprop="givenNames"><span
                itemprop="givenName">B</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Zhang</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MA Watson"><span data-itemprop="givenNames"><span
                itemprop="givenName">MA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Watson</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="PA Humphrey"><span data-itemprop="givenNames"><span
                itemprop="givenName">PA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Humphrey</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Lim"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lim</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Milbrandt"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Milbrandt</span></span></li>
        </ol><time itemprop="datePublished" datetime="2009">2009</time><span
          itemprop="headline">Loss of Nkx3.1 leads to the activation of discrete downstream target
          genes during prostate tumorigenesis</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">28</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Oncogene</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">3307</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">3319</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Loss%20of%20Nkx3.1%20leads%20to%20the%20activation%20of%20discrete%20downstream%20target%20genes%20during%20prostate%20tumorigenesis">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref047">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="I Grossman"><span data-itemprop="givenNames"><span
                itemprop="givenName">I</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Grossman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Alon"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Alon</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Ilani"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ilani</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Fass"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fass</span></span></li>
        </ol><time itemprop="datePublished" datetime="2013">2013</time><span itemprop="headline">An
          inhibitory antibody blocks the first step in the dithiol/disulfide relay mechanism of the
          enzyme QSOX1</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">425</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">J Mol
              Biol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">4366</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">4378</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=An%20inhibitory%20antibody%20blocks%20the%20first%20step%20in%20the%20dithiol/disulfide%20relay%20mechanism%20of%20the%20enzyme%20QSOX1">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref048">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Alon"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Alon</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="I Grossman"><span data-itemprop="givenNames"><span
                itemprop="givenName">I</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Grossman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Gat"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Gat</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="VK Kodali"><span data-itemprop="givenNames"><span
                itemprop="givenName">VK</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kodali</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="F DiMaio"><span data-itemprop="givenNames"><span
                itemprop="givenName">F</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">DiMaio</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Mehlman"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Mehlman</span></span></li>
        </ol><time itemprop="datePublished" datetime="2012">2012</time><span itemprop="headline">The
          dynamic disulphide relay of quiescin sulphydryl oxidase</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">488</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Nature</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">414</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">418</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=The%20dynamic%20disulphide%20relay%20of%20quiescin%20sulphydryl%20oxidase">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref049">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="CV Lee"><span data-itemprop="givenNames"><span
                itemprop="givenName">CV</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lee</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="W-C Liang"><span data-itemprop="givenNames"><span
                itemprop="givenName">W-C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Liang</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MS Dennis"><span data-itemprop="givenNames"><span
                itemprop="givenName">MS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dennis</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="C Eigenbrot"><span data-itemprop="givenNames"><span
                itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Eigenbrot</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SS Sidhu"><span data-itemprop="givenNames"><span
                itemprop="givenName">SS</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Sidhu</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Fuh"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fuh</span></span></li>
        </ol><time itemprop="datePublished" datetime="2004">2004</time><span
          itemprop="headline">High-affinity human antibodies from phage-displayed synthetic Fab
          libraries with a single framework scaffold</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">340</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">J Mol Biol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1073</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1093</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=High-affinity%20human%20antibodies%20from%20phage-displayed%20synthetic%20Fab%20libraries%20with%20a%20single%20framework%20scaffold">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref050">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="EH Kellogg"><span data-itemprop="givenNames"><span
                itemprop="givenName">EH</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kellogg</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Leaver-Fay"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Leaver-Fay</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Baker"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Baker</span></span></li>
        </ol><time itemprop="datePublished" datetime="2011">2011</time><span
          itemprop="headline">Role of conformational sampling in computing mutation-induced changes
          in protein structure and stability</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">79</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proteins</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">830</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">838</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Role%20of%20conformational%20sampling%20in%20computing%20mutation-induced%20changes%20in%20protein%20structure%20and%20stability">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref051">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Yin"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Yin</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="F Ding"><span data-itemprop="givenNames"><span
                itemprop="givenName">F</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ding</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="NV Dokholyan"><span data-itemprop="givenNames"><span
                itemprop="givenName">NV</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dokholyan</span></span></li>
        </ol><time itemprop="datePublished" datetime="2007">2007</time><span
          itemprop="headline">Eris: an automated estimator of protein stability</span><span
          itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">4</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Nat Methods</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">466</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">467</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Eris:%20an%20automated%20estimator%20of%20protein%20stability">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref052">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Jarasch"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Jarasch</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Koll"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Koll</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JT Regula"><span data-itemprop="givenNames"><span
                itemprop="givenName">JT</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Regula</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Bader"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Bader</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Papadimitriou"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Papadimitriou</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Kettenberger"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kettenberger</span></span></li>
        </ol><time itemprop="datePublished" datetime="2015">2015</time><span
          itemprop="headline">Developability assessment during the selection of novel therapeutic
          antibodies</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">104</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span itemprop="name">J
              Pharm Sci</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1885</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1898</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Developability%20assessment%20during%20the%20selection%20of%20novel%20therapeutic%20antibodies">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref053">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SE Boyken"><span data-itemprop="givenNames"><span
                itemprop="givenName">SE</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Boyken</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Z Chen"><span data-itemprop="givenNames"><span
                itemprop="givenName">Z</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Chen</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="B Groves"><span data-itemprop="givenNames"><span
                itemprop="givenName">B</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Groves</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="RA Langan"><span data-itemprop="givenNames"><span
                itemprop="givenName">RA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Langan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Oberdorfer"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Oberdorfer</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Ford"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ford</span></span></li>
        </ol><time itemprop="datePublished" datetime="2016">2016</time><span itemprop="headline">De
          novo design of protein homo-oligomers with modular hydrogen-bond network-mediated
          specificity</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">352</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Science</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">680</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">687</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=De%20novo%20design%20of%20protein%20homo-oligomers%20with%20modular%20hydrogen-bond%20network-mediated%20specificity">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref054">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Netzer"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Netzer</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
        </ol><time itemprop="datePublished" datetime="2016">2016</time><span
          itemprop="headline">Inspired by nature: designed proteins have structural features
          resembling those of natural active sites</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">352</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Science</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">657</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">658</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Inspired%20by%20nature:%20designed%20proteins%20have%20structural%20features%20resembling%20those%20of%20natural%20active%20sites">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref055">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Ben-Nissan"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ben-Nissan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Vimer"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Vimer</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Warszawski"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Warszawski</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Katz"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Katz</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Yona"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Yona</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Unger"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Unger</span></span></li>
        </ol><span itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
            itemprop="name">Rapid Characterization of Secreted Recombinant
            Proteins</span></span><span itemscope="" itemtype="http://schema.org/Organization"
          itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref056">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="BA Israel"><span data-itemprop="givenNames"><span
                itemprop="givenName">BA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Israel</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="L Jiang"><span data-itemprop="givenNames"><span
                itemprop="givenName">L</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Jiang</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SA Gannon"><span data-itemprop="givenNames"><span
                itemprop="givenName">SA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Gannon</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="C Thorpe"><span data-itemprop="givenNames"><span
                itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Thorpe</span></span></li>
        </ol><time itemprop="datePublished" datetime="2014">2014</time><span
          itemprop="headline">Disulfide bond generation in mammalian blood serum: detection and
          purification of quiescin-sulfhydryl oxidase</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">69</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Free Radic Biol Med</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">129</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">135</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Disulfide%20bond%20generation%20in%20mammalian%20blood%20serum:%20detection%20and%20purification%20of%20quiescin-sulfhydryl%20oxidase">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref057">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Chailyan"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Chailyan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Marcatili"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Marcatili</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Tramontano"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tramontano</span></span></li>
        </ol><time itemprop="datePublished" datetime="2011">2011</time><span itemprop="headline">The
          association of heavy and light chain variable domains in antibodies: implications for
          antigen specificity</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">278</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">FEBS J</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">2858</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">2866</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=The%20association%20of%20heavy%20and%20light%20chain%20variable%20domains%20in%20antibodies:%20implications%20for%20antigen%20specificity">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref058">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JC Almagro"><span data-itemprop="givenNames"><span
                itemprop="givenName">JC</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Almagro</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Teplyakov"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Teplyakov</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Luo"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Luo</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="RW Sweet"><span data-itemprop="givenNames"><span
                itemprop="givenName">RW</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Sweet</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Kodangattil"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kodangattil</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="F Hernandez-Guzman"><span
              data-itemprop="givenNames"><span itemprop="givenName">F</span></span><span
              data-itemprop="familyNames"><span itemprop="familyName">Hernandez-Guzman</span></span>
          </li>
        </ol><time itemprop="datePublished" datetime="2014">2014</time><span
          itemprop="headline">Second antibody modeling assessment (AMA-II)</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">82</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proteins: Struct Funct Bioinf</span></span></span><span
          itemprop="pageStart" data-itemtype="http://schema.org/Number">1553</span><span
          itemprop="pageEnd" data-itemtype="http://schema.org/Number">1562</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Second%20antibody%20modeling%20assessment%20(AMA-II)">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref059">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="CH Norn"><span data-itemprop="givenNames"><span
                itemprop="givenName">CH</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Norn</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Lapidoth"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lapidoth</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
        </ol><time itemprop="datePublished" datetime="2017">2017</time><span itemprop="headline"
          content="High-accuracy modeling of antibody structures by a search for minimum-energy recombination of backbone fragme…">High-accuracy
          modeling of antibody structures by a search for minimum-energy recombination of backbone
          fragments</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">85</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Proteins</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">30</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">38</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=High-accuracy%20modeling%20of%20antibody%20structures%20by%20a%20search%20for%20minimum-energy%20recombination%20of%20backbone%20fragme%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref060">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Lapidoth"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Lapidoth</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Parker"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Parker</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Prilusky"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Prilusky</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
        </ol><time itemprop="datePublished" datetime="2019">2019</time><span
          itemprop="headline">AbPredict 2: a server for accurate and unstrained structure prediction
          of antibody variable domains</span><span itemscope=""
          itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
            itemprop="issueNumber" data-itemtype="http://schema.org/Number">9</span><span
            itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
              itemprop="volumeNumber" data-itemtype="http://schema.org/Number">35</span><span
              itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                itemprop="name">Bioinformatics</span></span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1591</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">1593</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=AbPredict%202:%20a%20server%20for%20accurate%20and%20unstrained%20structure%20prediction%20of%20antibody%20variable%20domains">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref061">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JM Rini"><span data-itemprop="givenNames"><span
                itemprop="givenName">JM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Rini</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="U Schulze-Gahmen"><span data-itemprop="givenNames"><span
                itemprop="givenName">U</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Schulze-Gahmen</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="IA Wilson"><span data-itemprop="givenNames"><span
                itemprop="givenName">IA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wilson</span></span></li>
        </ol><time itemprop="datePublished" datetime="1992">1992</time><span
          itemprop="headline">Structural evidence for induced fit as a mechanism for
          antibody-antigen recognition</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">255</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Science</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">959</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">965</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Structural%20evidence%20for%20induced%20fit%20as%20a%20mechanism%20for%20antibody-antigen%20recognition">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref062">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="L Pauling"><span data-itemprop="givenNames"><span
                itemprop="givenName">L</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Pauling</span></span></li>
        </ol><time itemprop="datePublished" datetime="1940">1940</time><span itemprop="headline">A
          theory of the structure and process of formation of antibodies</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">62</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">J Am Chem Soc</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">2643</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">2657</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=A%20theory%20of%20the%20structure%20and%20process%20of%20formation%20of%20antibodies">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref063">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="RL Stanfield"><span data-itemprop="givenNames"><span
                itemprop="givenName">RL</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Stanfield</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Takimoto-Kamimura"><span
              data-itemprop="givenNames"><span itemprop="givenName">M</span></span><span
              data-itemprop="familyNames"><span
                itemprop="familyName">Takimoto-Kamimura</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JM Rini"><span data-itemprop="givenNames"><span
                itemprop="givenName">JM</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Rini</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="AT Profy"><span data-itemprop="givenNames"><span
                itemprop="givenName">AT</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Profy</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="IA Wilson"><span data-itemprop="givenNames"><span
                itemprop="givenName">IA</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wilson</span></span></li>
        </ol><time itemprop="datePublished" datetime="1993">1993</time><span
          itemprop="headline">Major antigen-induced domain rearrangements in an antibody</span><span
          itemscope="" itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">1</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Structure</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">83</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">93</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Major%20antigen-induced%20domain%20rearrangements%20in%20an%20antibody">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref064">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Elazar"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Elazar</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="J Weinstein"><span data-itemprop="givenNames"><span
                itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Weinstein</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="I Biran"><span data-itemprop="givenNames"><span
                itemprop="givenName">I</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Biran</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Fridman"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fridman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="E Bibi"><span data-itemprop="givenNames"><span
                itemprop="givenName">E</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Bibi</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
        </ol><time itemprop="datePublished" datetime="2016">2016</time><span itemprop="headline"
          content="Mutational scanning reveals the determinants of protein insertion and association energetics in the plasma me…">Mutational
          scanning reveals the determinants of protein insertion and association energetics in the
          plasma membrane</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
          itemprop="isPartOf"><span itemprop="volumeNumber"
            data-itemtype="http://schema.org/Number">5</span><span itemscope=""
            itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Elife</span></span></span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Mutational%20scanning%20reveals%20the%20determinants%20of%20protein%20insertion%20and%20association%20energetics%20in%20the%20plasma%20me%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref065">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Liu"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Liu</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JH Naismith"><span data-itemprop="givenNames"><span
                itemprop="givenName">JH</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Naismith</span></span></li>
        </ol><time itemprop="datePublished" datetime="2008">2008</time><span itemprop="headline">An
          efficient one-step site-directed deletion, insertion, single and multiple-site plasmid
          mutagenesis protocol</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">8</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">BMC Biotechnol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">91</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=An%20efficient%20one-step%20site-directed%20deletion,%20insertion,%20single%20and%20multiple-site%20plasmid%20mutagenesis%20protocol">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref066">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="RD Gietz"><span data-itemprop="givenNames"><span
                itemprop="givenName">RD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Gietz</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="RH Schiestl"><span data-itemprop="givenNames"><span
                itemprop="givenName">RH</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Schiestl</span></span></li>
        </ol><time itemprop="datePublished" datetime="2007">2007</time><span itemprop="headline"
          content="Frozen competent yeast cells that can be transformed with high efficiency using the LiAc/SS carrier DNA/PEG m…">Frozen
          competent yeast cells that can be transformed with high efficiency using the LiAc/SS
          carrier DNA/PEG method</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">2</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Nat Protoc</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">1</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">4</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Frozen%20competent%20yeast%20cells%20that%20can%20be%20transformed%20with%20high%20efficiency%20using%20the%20LiAc/SS%20carrier%20DNA/PEG%20m%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref067">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SJ Fleishman"><span data-itemprop="givenNames"><span
                itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fleishman</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Leaver-Fay"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Leaver-Fay</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="JE Corn"><span data-itemprop="givenNames"><span
                itemprop="givenName">JE</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Corn</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="E-M Strauch"><span data-itemprop="givenNames"><span
                itemprop="givenName">E-M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Strauch</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="SD Khare"><span data-itemprop="givenNames"><span
                itemprop="givenName">SD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Khare</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="N Koga"><span data-itemprop="givenNames"><span
                itemprop="givenName">N</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Koga</span></span></li>
        </ol><time itemprop="datePublished" datetime="2011">2011</time><span
          itemprop="headline">RosettaScripts: a scripting language interface to the Rosetta
          macromolecular modeling suite</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">6</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">PLoS One</span></span></span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=RosettaScripts:%20a%20scripting%20language%20interface%20to%20the%20Rosetta%20macromolecular%20modeling%20suite">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref068">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MJ O’Meara"><span data-itemprop="givenNames"><span
                itemprop="givenName">MJ</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">O’Meara</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Leaver-Fay"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Leaver-Fay</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MD Tyka"><span data-itemprop="givenNames"><span
                itemprop="givenName">MD</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tyka</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Stein"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Stein</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="K Houlihan"><span data-itemprop="givenNames"><span
                itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Houlihan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="F DiMaio"><span data-itemprop="givenNames"><span
                itemprop="givenName">F</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">DiMaio</span></span></li>
        </ol><time itemprop="datePublished" datetime="2015">2015</time><span
          itemprop="headline">Combined covalent-electrostatic model of hydrogen bonding improves
          structure prediction with Rosetta</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">11</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">J Chem Theory Comput</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">609</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">622</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Combined%20covalent-electrostatic%20model%20of%20hydrogen%20bonding%20improves%20structure%20prediction%20with%20Rosetta">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref069">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Park"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Park</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Bradley"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Bradley</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="P Greisen"><span data-itemprop="givenNames"><span
                itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Greisen</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Liu"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Liu</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="VK Mulligan"><span data-itemprop="givenNames"><span
                itemprop="givenName">VK</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Mulligan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="DE Kim"><span data-itemprop="givenNames"><span
                itemprop="givenName">DE</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kim</span></span></li>
        </ol><time itemprop="datePublished" datetime="2016">2016</time><span
          itemprop="headline">Simultaneous Optimization of Biomolecular Energy Functions on Features
          from Small Molecules and Macromolecules</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">12</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">J Chem Theory Comput</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">6201</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">6212</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Simultaneous%20Optimization%20of%20Biomolecular%20Energy%20Functions%20on%20Features%20from%20Small%20Molecules%20and%20Macromolecules">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref070">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Ben-Nissan"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Ben-Nissan</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="ME Belov"><span data-itemprop="givenNames"><span
                itemprop="givenName">ME</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Belov</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="D Morgenstern"><span data-itemprop="givenNames"><span
                itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Morgenstern</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Levin"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Levin</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="O Dym"><span data-itemprop="givenNames"><span
                itemprop="givenName">O</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dym</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="G Arkind"><span data-itemprop="givenNames"><span
                itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Arkind</span></span></li>
        </ol><time itemprop="datePublished" datetime="2017">2017</time><span
          itemprop="headline">Triple-Stage Mass Spectrometry Unravels the Heterogeneity of an
          Endogenous Protein Complex</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">89</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">Anal Chem</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">4708</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">4715</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Triple-Stage%20Mass%20Spectrometry%20Unravels%20the%20Heterogeneity%20of%20an%20Endogenous%20Protein%20Complex">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref071">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="N Kirshenbaum"><span data-itemprop="givenNames"><span
                itemprop="givenName">N</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Kirshenbaum</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="I Michaelevski"><span data-itemprop="givenNames"><span
                itemprop="givenName">I</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Michaelevski</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Sharon"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Sharon</span></span></li>
        </ol><time itemprop="datePublished" datetime="2010">2010</time><span
          itemprop="headline">Analyzing large protein complexes by structural mass
          spectrometry</span><span itemscope="" itemtype="http://schema.org/Periodical"
          itemprop="isPartOf"><span itemprop="name">J Vis Exp</span></span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Analyzing%20large%20protein%20complexes%20by%20structural%20mass%20spectrometry">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref072">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Tiller"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tiller</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="E Meffre"><span data-itemprop="givenNames"><span
                itemprop="givenName">E</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Meffre</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="S Yurasov"><span data-itemprop="givenNames"><span
                itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Yurasov</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="M Tsuiji"><span data-itemprop="givenNames"><span
                itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Tsuiji</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="MC Nussenzweig"><span data-itemprop="givenNames"><span
                itemprop="givenName">MC</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Nussenzweig</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="H Wardemann"><span data-itemprop="givenNames"><span
                itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Wardemann</span></span></li>
        </ol><time itemprop="datePublished" datetime="2008">2008</time><span itemprop="headline"
          content="Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression …">Efficient
          generation of monoclonal antibodies from single human B cells by single cell RT-PCR and
          expression vector cloning</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">329</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">J Immunol Methods</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">112</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">124</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Efficient%20generation%20of%20monoclonal%20antibodies%20from%20single%20human%20B%20cells%20by%20single%20cell%20RT-PCR%20and%20expression%20%E2%80%A6">
      </li>
      <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
        id="pcbi-1007207-ref073">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="T Unger"><span data-itemprop="givenNames"><span
                itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Unger</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Jacobovitch"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Jacobovitch</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="A Dantes"><span data-itemprop="givenNames"><span
                itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Dantes</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="R Bernheim"><span data-itemprop="givenNames"><span
                itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Bernheim</span></span></li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Y Peleg"><span data-itemprop="givenNames"><span
                itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Peleg</span></span></li>
        </ol><time itemprop="datePublished" datetime="2010">2010</time><span
          itemprop="headline">Applications of the Restriction Free (RF) cloning procedure for
          molecular manipulations and protein expression</span><span itemscope=""
          itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
            itemprop="volumeNumber" data-itemtype="http://schema.org/Number">172</span><span
            itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
              itemprop="name">J Struct Biol</span></span></span><span itemprop="pageStart"
          data-itemtype="http://schema.org/Number">34</span><span itemprop="pageEnd"
          data-itemtype="http://schema.org/Number">44</span><span itemscope=""
          itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span></span>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Applications%20of%20the%20Restriction%20Free%20(RF)%20cloning%20procedure%20for%20molecular%20manipulations%20and%20protein%20expression">
      </li>
    </ol>
  </section>
</article>